# EDGAR Filing Document

**Accession Number:** 0002034400
**File Stem:** 0001493152-25-015711
**Filing Date:** 2025-9
**Character Count:** 236885
**Document Hash:** 2790115898cd08117edd6055289b9f8d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-015711.hdr.sgml**: 20250926

**ACCESSION NUMBER**: 0001493152-25-015711

**CONFORMED SUBMISSION TYPE**: POS AM

**PUBLIC DOCUMENT COUNT**: 11

**FILED AS OF DATE**: 20250926

**DATE AS OF CHANGE**: 20250926

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Black Titan Corp
- **CENTRAL INDEX KEY:** 0002034400
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** POS AM
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-287709
- **FILM NUMBER:** 251350435

**BUSINESS ADDRESS:**
- **STREET 1:** 10 EAST 53RD STREET
- **STREET 2:** SUITE 3001
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022-5064
- **BUSINESS PHONE:** 6012-484 4444

**MAIL ADDRESS:**
- **STREET 1:** 10 EAST 53RD STREET
- **STREET 2:** SUITE 3001
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022-5064

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BSKE Ltd.
- **DATE OF NAME CHANGE:** 20240819

**As filed with the U.S. Securities and Exchange Commission on September 26, 2025.**

**Registration No. 333-287709**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM F-4**

**Post-Effective Amendment No. 1**

**REGISTRATION STATEMENT**

**UNDER**

**THE SECURITIES ACT OF 1933**

**Black Titan Corporation**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **7371** | **Not Applicable** |
| (State or Other Jurisdiction of<br> Incorporation or Organization) | (Primary Standard Industrial<br> Classification Code Number) | (I.R.S. Employer <br> Identification No.) |

---

**c/o FFP (Corporate Services) Limited**

**2nd Floor Harbour Centre**

**159 Mary Street**

**George Town**

**Grand Cayman KY1-9006**

**Cayman Islands**

**1 (345) 947 5854**

(Address, including zip code, and telephone number, including area code,

of registrant's principal executive offices)

**FFP (Corporate Services) Limited**

**2nd Floor Harbour Centre**

**159 Mary Street**

**George Town**

**Grand Cayman KY1-9006**

**Cayman Islands**

**+1 (345) 947 5854**

(Name, address, including zip code, and telephone number, including area code, of agent for service)

***Copies to:***

---

| | |
|:---|:---|
| **Kenneth A. Schlesinger, Esq.**<br> **Claudia B. Dubon, Esq.**<br> **Olshan Frome Wolosky LLP**<br> **1325 Avenue of the Americas,**<br> **15th Floor**<br> **New York, New York 10019**<br> **(212) 451-2300** | **Mitchell Nussbaum, Esq.**<br> **Tahra Wright, Esq.**<br> **Loeb & Loeb LLP**<br> **345 Park Avenue**<br> **New York, NY 10154**<br> **(212) 407-4000** |

---

**Approximate date of commencement of proposed sale of the securities to the public: As soon as practicable after this Registration Statement becomes effective and after all conditions under the Merger Agreement to consummate the proposed merger are satisfied or waived.**

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering: ☐

If applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction: Exchange Act Rule 13e-4(i) (Cross-Border Issuer Tender Offer) ☐

Exchange Act Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) ☐

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards<sup>†</sup> provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**This Post-Effective Amendment No. 1 to Registration Statement on Form F-4 (No. 333-287709) shall hereafter become effective in accordance with the provisions of Section 8(c) of the Securities Act of 1933, as amended.**

† The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

**EXPLANATORY NOTE**

This Post-Effective Amendment No. 1 ("***Amendment***") to this Registration Statement on Form F-4 (Registration No. 333-287709) (the "***Registration Statement***") is being filed solely for the purposes of filing Exhibit 3.2, as amended, updating Exhibit 10.7, and filing Exhibits 5.1, 5.2, 8.1, 23.3, 23.4, and 23.5, and accordingly amending the Exhibit Index set forth in Part II of the Registration Statement. This Amendment consists solely of the cover page, this explanatory note and Part II of the Registration Statement.

**PART II**

**INFORMATION NOT REQUIRED IN PROSPECTUS**

**Item 20. Indemnification of Directors and Officers**

Cayman Islands law does not limit the extent to which a company's memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Islands courts to be contrary to public policy, such as to provide indemnification against willful default, willful neglect, civil fraud or the consequences of committing a crime. The PubCo Charter shall provide for indemnification of our officers and directors to the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through their own fraud or dishonesty.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is theretofore unenforceable.

**Item 21. Exhibits and Financial Statement Schedules**

**EXHIBIT INDEX**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | Incorporated by Reference | Incorporated by Reference | Incorporated by Reference | Incorporated by Reference |
| Exhibit | Description | Schedule/Form | File Number | Exhibits | Filing Date |
| 2.1\*\* | [Agreement and Plan of Merger, dated as of August 19, 2024 (included as Annex A to the proxy statement/prospectus).](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/formf-4.htm#anna_001) |  |  |  |  |
| 3.1.1\*\* | [Amended and Restated Certificate of Incorporation of the TTNP, as amended.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex3-1_1.htm) |  |  |  |  |
| 3.1.2\*\* | [Certificate of Amendment to TTNP Restated Certificate of Incorporation dated September 24, 2015.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex3-1_2.htm) |  |  |  |  |
| 3.1.3\*\* | [Certificate of Amendment to TTNP Restated Certificate of Incorporation dated January 23, 2019.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex3-1_3.htm) |  |  |  |  |
| 3.1.4\*\* | [Certificate of Amendment to TTNP Restated Certificate of Incorporation dated November 30, 2020.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex3-1_4.htm) |  |  |  |  |
| 3.1.5\*\* | [Certificate of Amendment to TTNP Amended and Restated Certificate of Incorporation dated January 8, 2024.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex3-1_5.htm) |  |  |  |  |
| 3.2+ | [PubCo Fourth Amended and Restated Memorandum of Association and Fourth Amended and Restated Articles of Association](ex3-2.htm) |  |  |  |  |
| 4.1\*\* | [Form of TTNP Lender Warrant.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex4-1.htm) |  |  |  |  |
| 4.2\*\* | [Form of TTNP Rights Agreement.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex4-2.htm) |  |  |  |  |
| 4.5\*\* | [Form of TTNP January 2020 Private Placement Warrant.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex4-5.htm) |  |  |  |  |
| 4.6\*\* | [Form of TTNP March 3, 2020 Warrant Amendment Agreement.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex4-6.htm) |  |  |  |  |
| 4.7\*\* | [Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Warrant.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex4-7.htm) |  |  |  |  |
| 4.8\*\* | [Form of TTNP January 2021 Private Placement Warrant.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex4-8.htm) |  |  |  |  |
| 4.9\*\* | [Form of TTNP February 2022 Placement Warrant.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex4-9.htm) |  |  |  |  |
| 4.10\*\* | [TTNP Certificate of Designations, Preferences and Rights of Series AA Convertible Preferred Stock.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex4-10.htm) |  |  |  |  |
| 4.11\*\* | [TTNP Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex4-11.htm) |  |  |  |  |
| 4.12\*\* | [Certificate of Designations for Series A Preferred Shares of Black Titan Corporation](https://www.sec.gov/Archives/edgar/data/2034400/000164117225016098/ex4-12.htm) |  |  |  |  |
| 4.13\*\* | [TTNP Certificate of Designations, Preferences and Rights of Series C Convertible Preferred Stock.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225017871/ex4-13.htm) |  |  |  |  |
| 5.1+ | [Opinion of Harney Westwood & Riegels (Cayman) LLP](ex5-1.htm) |  |  |  |  |
| 5.2+ | [Opinion of Loeb & Loeb LLP](ex5-2.htm) |  |  |  |  |
| 8.1+ | [Opinion of Olshan Frome Wolosky LLP](ex8-1.htm) |  |  |  |  |
| 10.1\*\* | [License Agreement between Titan Pharmaceuticals, Inc. and Ocular Therapeutix, Inc., dated as of December 6, 2022.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-1.htm) |  |  |  |  |
| 10.2\*\* | [Asset Purchase Agreement between Titan Pharmaceuticals, Inc. and Fedson, Inc., dated as of July 26, 2023.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-2.htm) |  |  |  |  |
| 10.3\*\* | [Amendment and Extension Agreement between Titan Pharmaceuticals, Inc. and Fedson, Inc., dated as of August 25, 2023.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-3.htm) |  |  |  |  |
| 10.4\*\* | [Form of Securities Purchase Agreement, dated as of September 13, 2023, by and among TTNP and The Sire Group Ltd.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-4.htm) |  |  |  |  |
| 10.5\*\* | [Form of Registration Rights Agreement, dated as of September 13, 2023, by and among TTNP and The Sire Group Ltd.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-5.htm) |  |  |  |  |
| 10.6\*\* | [Convertible Promissory Note between Titan Pharmaceuticals, Inc. and Choong Choon Hau.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-6.htm) |  |  |  |  |
| 10.7+ | [Share Exchange Agreement](ex10-7.htm) |  |  |  |  |
| 10.8\*\* | [Lease between registrant and Boustead Nucleus Sdn Bhd, dated 29 August 2024.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-8.htm) |  |  |  |  |
| 10.9\*\* | [Letter of Appointment between KE Systems Sdn. Bhd. and Ho Say San, dated 1 February 1988 and Annual Review letter dated 8 August 2023.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-9.htm) |  |  |  |  |
| 10.10 | [Reserved] |  |  |  |  |
| 10.11\*\* | [Letter of engagement between Sire and ARC Group Limited, dated January 11, 2023, as amended.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-11.htm) |  |  |  |  |
| 10.12\*\* | [Consulting Services Agreement, dated 2024, between Sire and TalenTec, as amended.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-12.htm) |  |  |  |  |
| 10.13\*\* | [Credit Facility –between TalenTec and Alliance Bank, dated 28 April 2020.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-13.htm) |  |  |  |  |
| 10.14\*\* | [Credit Facilities – between TalenTec and Alliance Bank, dated 08 November 2021.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-14.htm) |  |  |  |  |
| 10.15\*\* | [Facility Agreement between TalenTec and Alliance Bank Malaysia Berhad, dated 29 August 2021, as amended.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-15.htm) |  |  |  |  |
| 10.16\*\* | [Amended and Restated Investment Agreement, dated July 25, 2024, between Goh Chee Siong and TalenTec and the other TalenTec Shareholders.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-16.htm) |  |  |  |  |
| 10.17\*\* | [Form of Registration Rights Agreement.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-17.htm) |  |  |  |  |
| 10.18\*\* | [Form of Securities Purchase Agreement, dated as of March 29, 2025, by and among TTNP and Blue Harbour Asset Management L.L.C-FZ.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-18.htm) |  |  |  |  |
| 10.19\*\* | [Registration Rights Agreement, dated as of March 29, 2025, by and among TTNP and Blue Harbour Asset Management L.L.C-FZ.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex10-19.htm) |  |  |  |  |
| 10.20\*\* | [Form of Preferred Shares Subscription Agreement of Black Titan Corporation](https://www.sec.gov/Archives/edgar/data/2034400/000164117225016098/ex10-20.htm) |  |  |  |  |
| 10.21\*\* | [Form of Securities Purchase Agreement, dated as of June 24, 2025, by and among the Company and Blue Harbour Asset Management L.L.C-FZ.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225017871/ex10-21.htm) |  |  |  |  |
| 10.22\*\* | [Form of Registration Rights Agreement, dated as of June 24, 2025, by and among the Company and Blue Harbour Asset Management L.L.C-FZ.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225017871/ex10-22.htm) |  |  |  |  |
| 21.1\*\* | [TalenTec list of subsidiaries: Keda Pte. Ltd., incorporated in Singapore.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex21-1.htm) |  |  |  |  |
| 23.1\*\* | [Consent of WithumSmith+Brown, PC.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225017871/ex23-1.htm) |  |  |  |  |
| 23.2\*\* | [Consent of Enrome LLP.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225017871/ex23-2.htm) |  |  |  |  |
| 23.3+ | [Consent of Harney Westwood & Riegels (Cayman) LLP (included in Exhibit 5.1)](ex5-1.htm) |  |  |  |  |
| 23.4+ | [Consent of Loeb & Loeb LLP (included in Exhibit 5.2)](ex5-2.htm) |  |  |  |  |
| 23.5+ | [Consent of Olshan Frome Wolosky LLP (included in Exhibit 8.1)](ex8-1.htm) |  |  |  |  |
| 99.1\*\* | [Form of Proxy Card for Titan Pharmaceuticals, Inc.'s Special Meeting of Stockholders.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex99-1.htm) |  |  |  |  |
| 99.2\*\* | [Opinion of King Kee Appraisal and Advisory Limited (included as Annex C to the proxy statement/prospectus).](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/formf-4.htm#k_002) |  |  |  |  |
| 99.3\*\* | [Consent of Avraham Ben-Tzvi to be named as a director.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex99-3.htm) |  |  |  |  |
| 99.4\*\* | [Consent of Brynner Chiam to be named as a director.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex99-4.htm) |  |  |  |  |
| 99.5\*\* | [Consent of Francisco Osvaldo Flores García to be named as a director.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex99-5.htm) |  |  |  |  |
| 99.6\*\* | [Consent of Firdauz Edmin Bin Mokhtar to be named as a director.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex99-6.htm) |  |  |  |  |
| 99.7\*\* | [Consent of Gabriel Loh to be named as a director.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex99-7.htm) |  |  |  |  |
| 99.8\*\* | [Consent of King Kee Appraisal and Advisory Limited, included as Annex C to the proxy statement/prospectus.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/formf-4.htm#k_002) |  |  |  |  |
| 99.9\*\* | [Consent of Mordor.](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex99-9.htm) |  |  |  |  |
| 107\*\* | [Filing Fee Table](https://www.sec.gov/Archives/edgar/data/2034400/000164117225013128/ex107.htm) |  |  |  |  |

---

---

| | |
|:---|:---|
| \* | To be filed by amendment |
| \*\* | Previously filed |
| + | Filed herewith |
| [# | Certain exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). PubCo agrees to furnish supplementally a copy of any omitted exhibit or schedule to the SEC upon its request; however, PubCo may request confidential treatment of omitted items.] |
| [## | Certain confidential portions of this exhibit were omitted by means of marking such portions with brackets and asterisks because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed, or constituted personally identifiable information that is not material.] |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in New York, on September 26, 2025.

---

| | |
|:---|:---|
| **Black Titan Corporation** | **Black Titan Corporation** |
| By: | */s/ Brynner Chiam* |
| Name: | Brynner Chiam |
| Title: | Chief Executive Officer (principal executive officer), Chief Financial Officer (principal financial and accounting officer) and Director |

---

**POWER OF ATTORNEY**

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Chay Weei Jye his/her true and lawful attorney-in-fact, with full power of substitution and resubstitution for him and in his name, place and stead, in any and all capacities to sign any and all amendments including pre- and post-effective amendments to this registration statement, any subsequent registration statement for the same offering which may be filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and pre- or post-effective amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact or his substitute, each acting alone, may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following on September 26, 2025 in the capacities indicated.

---

| | |
|:---|:---|
| **Name** | **Title** |
| */s/ Brynner Chiam* | Chief Executive Officer (principal executive officer), Chief Financial Officer (principal financial and accounting officer) and Director |
| Brynner Chiam |  |
| */s/ Chay Weei Jye* | Director Nominee |
| Chay Weei Jye |  |
| */s/ Firdauz Edmin Bin Mokhtar\** | Director Nominee |
| Firdauz Edmin Bin Mokhtar |  |
| */s/ Francsico Osvaldo\** | Director Nominee |
| Francsico Osvaldo |  |
| */s/ Avraham Ben Tzvi\** | Director Nominee |
| Avraham Ben Tzvi |  |
| */s/ Gabriel Loh\** | Director Nominee |
| Gabriel Loh |  |

---

---

| | |
|:---|:---|
| \*By: | */s/ Chay Weei Jye* |
|  | Chay Wei Jye, |
|  | Attorney-in-fact |

---

**AUTHORIZED REPRESENTATIVE**

Pursuant to the requirements of Section 6(a) of the Securities Act of 1933, the undersigned has signed this amended registration statement, solely in its capacity as the duly authorized representative of Black Titan Corporation, in New York on the 26th day of September, 2025.

---

| | |
|:---|:---|
| By: | */s/ Brynner Chiam* |
| Name: | Brynner Chiam |
| Title: | Chief Executive Officer (principal executive officer), Chief Financial Officer (principal financial and accounting officer) and Director |

---

## Exhibit 3.2

**Exhibit 3.2**

**THE COMPANIES ACT (2025 REVISION)**

**OF THE CAYMAN ISLANDS**

**COMPANY LIMITED BY SHARES**

**FOURTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION**

**OF**

**BLACK TITAN CORPORATION**

**(Adopted by Special Resolution dated 18 September 2025 and effective on 18 September 2025)**

**THE COMPANIES ACT (2025 REVISION)**

**OF THE CAYMAN ISLANDS** 

**COMPANY LIMITED BY SHARES**

**FOURTH AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION** 

**OF**

**BLACK TITAN CORPORATION**

**An Exempted Company Limited By Shares** 

**(Adopted by Special Resolution dated 18 September 2025 and effective on 18 September 2025)**

---

| | |
|:---|:---|
| **1** | **Name** |

---

The name of the Company is Black Titan Corporation.

---

| | |
|:---|:---|
| **2** | **Registered Office** |

---

The registered office of the Company is at FFP (Corporate Services) Limited, 2nd Floor Harbour Centre, 159 Mary Street, George Town, Grand Cayman KY1-9006, Cayman Islands or at such other place as the Directors may from time to time decide.

---

| | |
|:---|:---|
| **3** | **Objects** |

---

The objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any object not prohibited by the laws of the Cayman Islands.

---

| | |
|:---|:---|
| **4** | **Liability of Members** |

---

The liability of each Member is limited to the amount unpaid on such Member's shares.

---

| | |
|:---|:---|
| **5** | **Share Capital** |

---

The authorised share capital of the Company is USD $1,050,000 divided into 1,000,000,000 Ordinary Shares of par value $0.001 par value each and 50,000,000 Preferred Shares of par value $0.001 each. Subject to the Companies Act (2025 Revision) and the Company's articles of association, the Company has power to do any one or more of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) redeem
 or repurchase any of its shares;

(b) increase
 or reduce its capital;

(c) issue
 any part of its capital (whether original, redeemed, increased or reduced):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) with
 or without any preferential, deferred, qualified or special rights, privileges or conditions;
 or

(ii) subject
 to any limitations or restrictions, and unless the condition of issue expressly declares
 otherwise, every issue of shares (whether declared to be ordinary, preference or otherwise)
 is subject to this power; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) alter
 any of those rights, privileges, conditions, limitations or restrictions.

---

| | |
|:---|:---|
| **6** | **Liability of Members** |

---

The liability of each Member is limited to the amount from time to time unpaid on such Member's Shares.

---

| | |
|:---|:---|
| **7** | **Continuation** |

---

The Company has power to register by way of continuation as a body corporate limited by shares under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.

---

| | |
|:---|:---|
| **8** | **Definitions** |

---

Capitalised terms that are not defined in this Amended and Restated Memorandum of Association bear the respective meanings given to them in the Amended and Restated Articles of Association of the Company.

---

| | |
|:---|:---|
| **9** | **Financial Year** |

---

The financial year end of the Company is 31 July or such other date as the Directors may from time to time decide.

**THE COMPANIES ACT (2025 REVISION)**

**OF THE CAYMAN ISLANDS** 

**COMPANY LIMITED BY SHARES**

**FOURTH AMENDED AND RESTATED ARTICLES OF ASSOCIATION** 

**OF**

**BLACK TITAN CORPORATION**

**An Exempted Company Limited By Shares**

**(Adopted by Special Resolution dated 18 September 2025 and effective on 18 September 2025)**

---

| | |
|:---|:---|
| **1** | **Interpretation** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 In
 the Articles Table A in the First Schedule to the Statute does not apply and, unless there
 is something in the subject or context inconsistent therewith:

---

| | |
|:---|:---|
| "***Applicable Law***" | means, with respect to any person, all provisions of laws, statutes, ordinances, rules, regulations, permits, certificates, judgments, decisions, decrees or orders of any governmental authority applicable to such person.<br>|
| "***Articles***" | means these amended and restated articles of association of the Company.<br>|
| "***Audit Committee***" | means the audit committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.<br>|
| "***Auditor***" | means the person for the time being performing the duties of auditor of the Company (if any).<br>|
| ***"Business Combination"*** | has the meaning given in the Merger and Contribution Agreement.<br>|
| "***Clearing House***" | means a clearing house recognised by the laws of the jurisdiction in which the Shares (or depositary receipts therefor) are listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction. |

---

---

| | |
|:---|:---|
| ***"Commission"*** <br>| means the United States Securities and Exchange Commission. |
| "***Company's Website***" | means the website of the Company and/or its web-address or domain name (if any).<br>|
| "***Compensation Committee***" | means the compensation committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.<br>|
| "***Designated Stock Exchange***" | means any United States national securities exchange on which the securities of the Company are listed for trading, including The NASDAQ Stock Market.<br>|
| "***Directors***" | means the directors for the time being of the Company.<br>|
| "***Dividend***" | means any dividend (whether interim or final) resolved to be paid on Shares pursuant to the Articles.<br>|
| ***"Effective Date"***<br>| <br> The date on which Shares in the Company are admitted to trading on a Designated Stock Exchange.<br>|
| "***Electronic Communication***" | means a communication sent by electronic means, including electronic posting to the Company's Website, transmission to any number, address or internet website (including the website of the Securities and Exchange Commission) or other electronic delivery methods as otherwise decided and approved by the Directors. |
| "***Electronic Record***" | has the same meaning as in the Electronic Transactions Act.<br>|
| "***Electronic Transactions Act***" | means the Electronic Transactions Act (As Revised) of the Cayman Islands.<br>|

---

---

| | |
|:---|:---|
| "***Exchange Act***" | means the United States Securities Exchange Act of 1934, as amended, or any similar United States federal statute and the rules and regulations of the Securities and Exchange Commission thereunder, all as the same shall be in effect at the time.<br>|
| "***Independent Director***" | has the same meaning as in the rules and regulations of the Designated Stock Exchange or in Rule 10A-3 under the Exchange Act, as the case may be.<br>|
| "***Liquidation*"** | has the meaning given in Paragraph 3.4 of the Schedule.<br>|
| "***Member***" | has the same meaning as in the Statute.<br>|
| "***Memorandum***" | means the amended and restated memorandum of association of the Company.<br>|
| "***Merger and Contribution Agreement"***<br>| means the Merger and Contribution and Share Exchange Agreement, entered into among the Company, Titan Pharmaceuticals, Inc., TTNP Merger Sub, Inc. and TalenTec Sdn. Bhd. on 19 August 2024.<br>|
| "***Nominating and Corporate Governance Committee"*** | means the nominating and corporate governance committee of the board of directors of the Company established pursuant to the Articles, or any successor committee. |
| "***Officer***" | means a person appointed to hold an office in the Company.<br>|
| "***Ordinary Resolution***" | means a resolution passed by a simple majority of the Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting, and where a poll is taken regard shall be had in computing a majority to the number of votes to which each shareholder is entitled.<br>|
| "***Ordinary Share***" | means an ordinary share of a par value of US$0.001 in the share capital of the Company.<br>|

---

---

| | |
|:---|:---|
| ***"Preferred Shares"***  | means the preferred shares of $0.001 par value each in the share capital of the Company.  |
| ***"Preferred Shareholder"*** | means a holder of Preferred Shares. |
| "***Register of Members***" | means the register of Members maintained in accordance with the Statute and includes (except where otherwise stated) any branch or duplicate register of Members.<br>|
| "***Registered Office***" | means the registered office for the time being of the Company. |
| "***Seal***" | means the common seal of the Company and includes every duplicate seal.<br>|
| "***Securities and Exchange Commission***" | means the United States Securities and Exchange Commission.  |
| "***Shares***" | means the Ordinary Shares and Preferred Shares and includes any class or series, and a fraction, of a share in the Company.<br>|
| "***Special Resolution***" | has the same meaning as in the Statute, and includes a unanimous written resolution.  |
| "***Statute***" | means the Companies Act (2025 Revision) of the Cayman Islands.  |
| ***"Treasury Share***" | means a Share held in the name of the Company as a treasury share in accordance with the Statute.<br>|

---

1.2 In
 the Articles:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) words
 importing the singular number include the plural number and vice versa;

(b) words
 importing the masculine gender include the feminine gender;

(c) words
 importing persons include corporations as well as any other legal or natural person;

(d) "written"
 and "in writing" include all modes of representing or reproducing words in visible
 form, including in the form of an Electronic Record;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) "shall"
 shall be construed as imperative and "may" shall be construed as permissive;

(f) references
 to provisions of any law or regulation shall be construed as references to those provisions
 as amended, modified, re-enacted or replaced;

(g) any
 phrase introduced by the terms "including", "include", "in
 particular" or any similar expression shall be construed as illustrative and shall
 not limit the sense of the words preceding those terms;

(h) the
 term "and/or" is used to mean both "and" as well as "or."
 The use of "and/or" in certain contexts in no respects qualifies or modifies
 the use of the terms "and" or "or" in others. The term "or"
 shall not be interpreted to be exclusive and the term "and" shall not be interpreted
 to require the conjunctive (in each case, unless the context otherwise requires);

(i) headings
 are inserted for reference only and shall be ignored in construing the Articles;

(j) any
 requirements as to delivery under the Articles include delivery in the form of an Electronic
 Record;

(k) any
 requirements as to execution or signature under the Articles including the execution of the
 Articles themselves can be satisfied in the form of an electronic signature as defined in
 the Electronic Transactions Act;

(l) sections
 8 and 19(3) of the Electronic Transactions Act shall not apply;

(m) the
 term "clear days" in relation to the period of a notice means that period excluding
 the day when the notice is received or deemed to be received and the day for which it is
 given or on which it is to take effect; and

(n) the
 term "holder" in relation to a Share means a person whose name is entered in
 the Register of Members as the holder of such Share.

---

| | |
|:---|:---|
| **2** | **Commencement of Business** |

---

2.1 The
 business of the Company may be commenced as soon after incorporation of the Company as the
 Directors shall see fit.

2.2 The
 Directors may pay, out of the capital or any other monies of the Company, all expenses incurred
 in or about the formation and establishment of the Company, including the expenses of registration.

---

| | |
|:---|:---|
| **3** | **Issue of Shares and other Securities** |

---

3.1 Subject
 to the provisions, if any, in the Memorandum (and to any direction that may be given by the
 Company in general meeting) and, where applicable, the rules and regulations of the Designated
 Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory
 authority or otherwise under Applicable Law, and without prejudice to any rights attached
 to any existing Shares, the Directors may allot, issue, grant options over or otherwise dispose
 of Shares in separate classes and/or series (including fractions of a Share) with or without
 preferred, deferred or other rights or restrictions, whether in regard to Dividends or other
 distributions, voting, return of capital or otherwise and to such persons, at such times
 and on such other terms as they think proper, and may also (subject to the Statute and the
 Articles) vary such rights.

3.2 The
 Company may issue rights, options, warrants or convertible securities or securities of similar
 nature conferring the right upon the holders thereof to subscribe for, purchase or receive
 any class or series of Shares or other securities in the Company on such terms as the Directors
 may from time to time determine.

3.3 The
 Company shall not issue Shares to bearer.

3.4 On
 or before the allotment of any Share, the Directors shall resolve the class and/or series
 to which such Share shall be classified and may, prior to the issue of any Share, reclassify
 such Share. Each class and/or series shall be specifically identified. Subject to the Statute
 and the Articles, the Directors may at any time re-name any Share.

---

| | |
|:---|:---|
| **4** | **Register of Members** |

---

4.1 The
 Company shall maintain or cause to be maintained the Register of Members in accordance with
 the Statute.

4.2 The
 Directors may determine that the Company shall maintain one or more branch registers of Members
 in accordance with the Statute. The Directors may also determine which register of Members
 shall constitute the principal register and which shall constitute the branch register or
 registers, and to vary such determination from time to time.

---

| | |
|:---|:---|
| **5** | **Closing Register of Members or Fixing Record Date** |

---

5.1 For
 the purpose of determining Members entitled to notice of, or to vote at any meeting of Members
 or any adjournment thereof, or Members entitled to receive payment of any Dividend or other
 distribution, or in order to make a determination of Members for any other purpose, the Directors
 may, after notice has been given by advertisement in an appointed newspaper or any other
 newspaper or by any other means in accordance with the rules and regulations of the Designated
 Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory
 authority or otherwise under Applicable Law, provide that the Register of Members shall be
 closed for transfers for a stated period which shall not in any case exceed 30 days.

5.2 In
 lieu of, or apart from, closing the Register of Members, the Directors may fix in advance
 or arrears a date as the record date for any such determination of Members entitled to notice
 of, or to vote at any meeting of the Members or any adjournment thereof, or for the purpose
 of determining the Members entitled to receive payment of any Dividend or other distribution,
 or in order to make a determination of Members for any other purpose.

5.3 If
 the Register of Members is not so closed and no record date is fixed for the determination
 of Members entitled to notice of, or to vote at, a meeting of Members or Members entitled
 to receive payment of a Dividend or other distribution, the date on which notice of the meeting
 is sent or the date on which the resolution of the Directors resolving to pay such Dividend
 or other distribution is passed, as the case may be, shall be the record date for such determination
 of Members. When a determination of Members entitled to vote at any meeting of Members has
 been made as provided in this Article, such determination shall apply to any adjournment
 thereof.

---

| | |
|:---|:---|
| **6** | **Rights of Shares** |

---

6.1 Where
 the Directors issue a Share having no preferred, deferred, redemption or other special rights,
 it shall be issued as an Ordinary Share and entitle the holder, subject to any other Share
 having any preferred, deferred, redemption or other special rights, to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) receive
 notice of, attend and vote at any general meeting of the Company and on any Ordinary Resolution
 or Special Resolution;

(b) an
 equal share in any dividend or other Distribution paid by the Company; and

(c) an
 equal share in the distribution of the surplus assets of the Company.

6.2 Shares
 and other securities of the Company may be issued by the Directors with such preferred, deferred
 or other special rights, restrictions or privileges whether in regard to voting, distributions,
 a return of capital, or otherwise and in such classes and series, if any, as the Directors
 may determine.

---

| | |
|:---|:---|
| **7** | **Certificates for Shares** |

---

7.1 A
 Member shall only be entitled to a share certificate if the Directors resolve that share
 certificates shall be issued. Share certificates representing Shares, if any, shall be in
 such form as the Directors may determine. Share certificates shall be signed by one or more
 Directors or other person authorised by the Directors. The Directors may authorise certificates
 to be issued with the authorised signature(s) affixed by mechanical process. All certificates
 for Shares shall be consecutively numbered or otherwise identified and shall specify the
 Shares to which they relate. All certificates surrendered to the Company for transfer shall
 be cancelled and, subject to the Articles, no new certificate shall be issued until the former
 certificate representing a like number of relevant Shares shall have been surrendered and
 cancelled.

7.2 The
 Company shall not be bound to issue more than one certificate for Shares held jointly by
 more than one person and delivery of a certificate to one joint holder shall be a sufficient
 delivery to all of them.

7.3 If
 a share certificate is defaced, worn out, lost or destroyed, it may be renewed on such terms
 (if any) as to evidence and indemnity and on the payment of such expenses reasonably incurred
 by the Company in investigating evidence, as the Directors may prescribe, and (in the case
 of defacement or wearing out) upon delivery of the old certificate.

7.4 Every
 share certificate sent in accordance with the Articles will be sent at the risk of the Member
 or other person entitled to the certificate. The Company will not be responsible for any
 share certificate lost or delayed in the course of delivery.

7.5 Share
 certificates shall be issued within the relevant time limit as prescribed by the Statute,
 if applicable, or as the rules and regulations of the Designated Stock Exchange, the Securities
 and Exchange Commission and/or any other competent regulatory authority or otherwise under
 Applicable Law may from time to time determine, whichever is shorter, after the allotment
 or, except in the case of a Share transfer which the Company is for the time being entitled
 to refuse to register and does not register, after lodgement of a Share transfer with the
 Company.

---

| | |
|:---|:---|
| **8** | **Transfer of Shares** |

---

8.1 Subject
 to the terms of the Articles, any Member may transfer all or any of their Shares by an instrument
 of transfer provided that such transfer complies with the rules and regulations of the Designated
 Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory
 authority or otherwise under Applicable Law. If the Shares in question were issued in conjunction
 with rights, options or warrants issued pursuant to the Articles on terms that one cannot
 be transferred without the other, the Directors shall refuse to register the transfer of
 any such Share without evidence satisfactory to them of the like transfer of such right,
 option or warrant.

8.2 The
 instrument of transfer of any Share shall be in writing in the usual or common form or in
 a form prescribed by the rules and regulations of the Designated Stock Exchange, the Securities
 and Exchange Commission and/or any other competent regulatory authority or otherwise under
 Applicable Law or in any other form approved by the Directors and shall be executed by or
 on behalf of the transferor (and if the Directors so require, signed by or on behalf of the
 transferee) and may be under hand or, if the transferor or transferee is a Clearing House
 or its nominee(s), by hand or by machine imprinted signature or by such other manner of execution
 as the Directors may approve from time to time. The transferor shall be deemed to remain
 the holder of a Share until the name of the transferee is entered in the Register of Members.

---

| | |
|:---|:---|
| **9** | **Redemption, Repurchase and Surrender of Shares** |

---

9.1 Subject
 to the provisions of the Statute, and, where applicable, the rules and regulations of the
 Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent
 regulatory authority or otherwise under Applicable Law, the Company may:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) issue
 Shares that are to be redeemed or are liable to be redeemed at the option of the Member or
 the Company. The redemption of such Shares shall be effected in such manner and upon such
 other terms as the Company may, by Special Resolution, determine before the issue of the
 Shares.

(b) purchase
 its own Shares (including any redeemable Shares) in such manner and on such other terms as
 the Directors may agree with the relevant Member.

For the avoidance of doubt, redemptions, repurchases and surrenders of Shares in the circumstances described in the Article above shall not require further approval of the Members.

9.2 The
 Company may make a payment in respect of the redemption or purchase of its own Shares in
 any manner permitted by the Statute, including out of capital.

9.3 The
 Directors may accept the surrender for no consideration of any fully paid Share.

---

| | |
|:---|:---|
| **10** | **Treasury Shares** |

---

10.1 The
 Directors may, prior to the purchase, redemption or surrender of any Share, determine that
 such Share shall be held as a Treasury Share.

10.2 The
 Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms
 as they think proper (including, without limitation, for nil consideration).

---

| | |
|:---|:---|
| **11** | **Variation of Rights of Shares** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.1 Subject
 to Article 3.1, if at any time the share capital of the Company is divided into different
 classes or series of Shares, all or any of the rights attached to any class (unless otherwise
 provided by the terms of issue of the Shares of that class) may, whether or not the Company
 is being wound up, be varied without the consent of the holders of the issued Shares of that
 class where such variation is considered by the Directors not to have a material adverse
 effect upon such rights; otherwise, any such variation shall be made only with the consent
 in writing of the holders of not less than two-thirds of the issued Shares of that class,
 or with the approval of a resolution passed by a majority of not less than two-thirds of
 the votes cast at a separate meeting of the holders of the Shares of that class. For the
 avoidance of doubt, the Directors reserve the right, notwithstanding that any such variation
 may not have a material adverse effect, to obtain consent from the holders of Shares of the
 relevant class. To any such meeting all the provisions of the Articles relating to general
 meetings shall apply *mutatis mutandis*, except that the necessary quorum shall be one
 person holding or representing by proxy at least one-third of the issued Shares of the class
 and that any holder of Shares of the class present in person or by proxy may demand a poll.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.2 For
 the purposes of a separate class meeting, the Directors may treat two or more or all the
 classes or series of Shares as forming one class or series of Shares if the Directors consider
 that such class or series of Shares would be affected in the same way by the proposals under
 consideration, but in any other case shall treat them as separate classes or series of Shares.

11.3 The
 rights conferred upon the holders of the Shares of any class issued with preferred or other
 rights shall not, unless otherwise expressly provided by the terms of issue of the Shares
 of that class, be deemed to be varied by the creation or issue of further Shares ranking
 pari passu therewith or Shares issued with preferred or other rights.

---

| | |
|:---|:---|
| **12** | **Commission on Sale of Shares** |

---

The Company may, in so far as the Statute permits, pay a commission to any person in consideration of that person subscribing or agreeing to subscribe (whether absolutely or conditionally) or procuring or agreeing to procure subscriptions (whether absolutely or conditionally) for any Shares. Such commissions may be satisfied by the payment of cash and/or the issue of fully or partly paid-up Shares. The Company may also on any issue of Shares pay such brokerage as may be lawful.

---

| | |
|:---|:---|
| **13** | **Non Recognition of Trusts** |

---

The Company shall not be bound by or compelled to recognise in any way (even when notified) any equitable, contingent, future or partial interest in any Share, or (except only as is otherwise provided by the Articles or the Statute) any other rights in respect of any Share other than an absolute right to the entirety thereof in the holder.

---

| | |
|:---|:---|
| **14** | **Lien on Shares** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.1 The
 Company shall have a first and paramount lien on all Shares (whether fully paid-up or not)
 registered in the name of a Member (whether solely or jointly with others) for all debts,
 liabilities or engagements to or with the Company (whether presently payable or not) by such
 Member or their estate, either alone or jointly with any other person, whether a Member or
 not, but the Directors may at any time declare any Share to be wholly or in part exempt from
 the provisions of this Article. The registration of a transfer of any such Share shall operate
 as a waiver of the Company's lien thereon. The Company's lien on a Share shall
 also extend to any amount payable in respect of that Share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.2 The
 Company may sell, in such manner as the Directors think fit, any Shares on which the Company
 has a lien, if a sum in respect of which the lien exists is presently payable, and is not
 paid within 14 clear days after notice has been received or deemed to have been received
 by the holder of the Shares, or to the person entitled to it in consequence of the death
 or bankruptcy of the holder, demanding payment and stating that if the notice is not complied
 with the Shares may be sold.

14.3 To
 give effect to any such sale the Directors may authorise any person to execute an instrument
 of transfer of the Shares sold to, or in accordance with the directions of, the purchaser.
 The purchaser or their nominee shall be registered as the holder of the Shares comprised
 in any such transfer, and they shall not be bound to see to the application of the purchase
 money, nor shall their title to the Shares be affected by any irregularity or invalidity
 in the sale or the exercise of the Company's power of sale under the Articles.

14.4 The
 net proceeds of such sale after payment of costs, shall be applied in payment of such part
 of the amount in respect of which the lien exists as is presently payable and any balance
 shall (subject to a like lien for sums not presently payable as existed upon the Shares before
 the sale) be paid to the person entitled to the Shares at the date of the sale.

---

| | |
|:---|:---|
| **15** | **Call on Shares** |

---

15.1 Subject
 to the terms of the allotment and issue of any Shares, the Directors may make calls upon
 the Members in respect of any monies unpaid on their Shares (whether in respect of par value
 or premium), and each Member shall (subject to receiving at least 14 clear days' notice
 specifying the time or times of payment) pay to the Company at the time or times so specified
 the amount called on the Shares. A call may be revoked or postponed, in whole or in part,
 as the Directors may determine. A call may be required to be paid by instalments. A person
 upon whom a call is made shall remain liable for calls made upon them notwithstanding the
 subsequent transfer of the Shares in respect of which the call was made.

15.2 A
 call shall be deemed to have been made at the time when the resolution of the Directors authorising
 such call was passed.

15.3 The
 joint holders of a Share shall be jointly and severally liable to pay all calls in respect
 thereof.

15.4 If
 a call remains unpaid after it has become due and payable, the person from whom it is due
 shall pay interest on the amount unpaid from the day it became due and payable until it is
 paid at such rate as the Directors may determine (and in addition all expenses that have
 been incurred by the Company by reason of such non-payment), but the Directors may waive
 payment of the interest or expenses wholly or in part.

15.5 An
 amount payable in respect of a Share on issue or allotment or at any fixed date, whether
 on account of the par value of the Share or premium or otherwise, shall be deemed to be a
 call and if it is not paid all the provisions of the Articles shall apply as if that amount
 had become due and payable by virtue of a call.

15.6 The
 Directors may issue Shares with different terms as to the amount and times of payment of
 calls, or the interest to be paid.

15.7 The
 Directors may, if they think fit, receive an amount from any Member willing to advance all
 or any part of the monies uncalled and unpaid upon any Shares held by that Member, and may
 (until the amount would otherwise become payable) pay interest at such rate as may be agreed
 upon between the Directors and the Member paying such amount in advance.

15.8 No
 such amount paid in advance of calls shall entitle the Member paying such amount to any portion
 of a Dividend or other distribution payable in respect of any period prior to the date upon
 which such amount would, but for such payment, become payable.

---

| | |
|:---|:---|
| **16** | **Forfeiture of Shares** |

---

16.1 If
 a call or instalment of a call remains unpaid after it has become due and payable the Directors
 may give to the person from whom it is due not less than 14 clear days' notice requiring
 payment of the amount unpaid together with any interest which may have accrued and any expenses
 incurred by the Company by reason of such non-payment. The notice shall specify where payment
 is to be made and shall state that if the notice is not complied with the Shares in respect
 of which the call was made will be liable to be forfeited.

16.2 If
 the notice is not complied with, any Share in respect of which it was given may, before the
 payment required by the notice has been made, be forfeited by a resolution of the Directors.
 Such forfeiture shall include all Dividends, other distributions or other monies payable
 in respect of the forfeited Share and not paid before the forfeiture.

16.3 A
 forfeited Share may be sold, re-allotted or otherwise disposed of on such terms and in such
 manner as the Directors think fit and at any time before a sale, re-allotment or disposition
 the forfeiture may be cancelled on such terms as the Directors think fit. Where for the purposes
 of its disposal a forfeited Share is to be transferred to any person the Directors may authorise
 some person to execute an instrument of transfer of the Share in favour of that person.

16.4 A
 person any of whose Shares have been forfeited shall cease to be a Member in respect of them
 and shall surrender to the Company for cancellation the certificate for the Shares forfeited
 and shall remain liable to pay to the Company all monies which at the date of forfeiture
 were payable by that person to the Company in respect of those Shares together with interest
 at such rate as the Directors may determine, but that person's liability shall cease
 if and when the Company shall have received payment in full of all monies due and payable
 by them in respect of those Shares.

16.5 A
 certificate in writing under the hand of one Director or Officer that a Share has been forfeited
 on a specified date shall be conclusive evidence of the facts stated in it as against all
 persons claiming to be entitled to the Share. The certificate shall (subject to the execution
 of an instrument of transfer) constitute a good title to the Share and the person to whom
 the Share is sold or otherwise disposed of shall not be bound to see to the application of
 the purchase money, if any, nor shall their title to the Share be affected by any irregularity
 or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the
 Share.

16.6 The
 provisions of the Articles as to forfeiture shall apply in the case of non-payment of any
 sum which, by the terms of issue of a Share, becomes payable at a fixed time, whether on
 account of the par value of the Share or by way of premium as if it had been payable by virtue
 of a call duly made and notified.

---

| | |
|:---|:---|
| **17** | **Transmission of Shares** |

---

17.1 If
 a Member dies, the survivor or survivors (where they were a joint holder), or their legal
 personal representatives (where they were a sole holder), shall be the only persons recognised
 by the Company as having any title to the deceased Member's Shares. The estate of a
 deceased Member is not thereby released from any liability in respect of any Share, for which
 the Member was a joint or sole holder.

17.2 Any
 person becoming entitled to a Share in consequence of the death or bankruptcy or liquidation
 or dissolution of a Member (or in any other way than by transfer) may, upon such evidence
 being produced as may be required by the Directors, elect, by a notice in writing sent by
 that person to the Company, either to become the holder of such Share or to have some person
 nominated by them registered as the holder of such Share. If they elect to have another person
 registered as the holder of such Share they shall sign an instrument of transfer of that
 Share to that person. The Directors shall, in either case, have the same right to decline
 or suspend registration as they would have had in the case of a transfer of the Share by
 the relevant Member before their death or bankruptcy or liquidation or dissolution, as the
 case may be.

17.3 A
 person becoming entitled to a Share by reason of the death or bankruptcy or liquidation or
 dissolution of a Member (or in any other case than by transfer) shall be entitled to the
 same Dividends, other distributions and other advantages to which they would be entitled
 if they were the holder of such Share. However, they shall not, before becoming a Member
 in respect of a Share, be entitled in respect of it to exercise any right conferred by membership
 in relation to general meetings of the Company and the Directors may at any time give notice
 requiring any such person to elect either to be registered or to have some person nominated
 by them registered as the holder of the Share (but the Directors shall, in either case, have
 the same right to decline or suspend registration as they would have had in the case of a
 transfer of the Share by the relevant Member before their death or bankruptcy or liquidation
 or dissolution or any other case than by transfer, as the case may be). If the notice is
 not complied with within 90 days of being received or deemed to be received (as determined
 pursuant to the Articles), the Directors may thereafter withhold payment of all Dividends,
 other distributions, bonuses or other monies payable in respect of the Share until the requirements
 of the notice have been complied with.

---

| | |
|:---|:---|
| **18** | **Amendments of Memorandum and Articles of Association and Alteration of Capital** |

---

18.1 The
 Company may by Ordinary Resolution:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) increase
 its share capital by such sum as the Ordinary Resolution shall prescribe and with such rights,
 priorities and privileges annexed thereto, as the Company in general meeting may determine;

(b) consolidate
 and divide all or any of its share capital into Shares of larger amount than its existing
 Shares;

(c) convert
 all or any of its paid-up Shares into stock, and reconvert that stock into paid-up Shares
 of any denomination;

(d) by
 subdivision of its existing Shares or any of them divide the whole or any part of its share
 capital into Shares of smaller amount than is fixed by the Memorandum or into Shares without
 par value; and

(e) cancel
 any Shares that at the date of the passing of the Ordinary Resolution have not been taken
 or agreed to be taken by any person and diminish the amount of its share capital by the amount
 of the Shares so cancelled.

18.2 All
 new Shares created in accordance with the provisions of the preceding Article shall be subject
 to the same provisions of the Articles with reference to the payment of calls, liens, transfer,
 transmission, forfeiture and otherwise as the Shares in the original share capital.

18.3 Subject
 to the provisions of the Statute and the provisions of the Articles as regards the matters
 to be dealt with by Ordinary Resolution, the Company may by Special Resolution:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) change
 its name;

(b) alter
 or add to the Articles;

(c) alter
 or add to the Memorandum with respect to any objects, powers or other matters specified therein;
 and

(d) reduce
 its share capital or any capital redemption reserve fund.

---

| | |
|:---|:---|
| **19** | **Offices and Places of Business** |

---

Subject to the provisions of the Statute, the Company may by resolution of the Directors change the location of its Registered Office. The Company may, in addition to its Registered Office, maintain such other offices or places of business as the Directors determine.

---

| | |
|:---|:---|
| **20** | **General Meetings** |

---

20.1 All
 general meetings other than annual general meetings shall be called extraordinary general
 meetings.

20.2 The
 Company may, but shall not (unless required by the Statute) be obliged to, in each year hold
 a general meeting as its annual general meeting, and shall specify the meeting as such in
 the notices calling it. Any annual general meeting shall be held at such time and place as
 the Directors shall appoint. At these meetings the report of the Directors (if any) shall
 be presented.

20.3 The
 Directors or the chairperson of the board of Directors may call general meetings, as they
 see fit and must do so if required to in accordance with Article 20.4.

20.4 Upon
 the written request ( ***General Meeting Request*** *)* of Members entitled to
 exercise 20% or more of the voting rights in respect of the matter for which the meeting
 is requisitioned, any one or more of the Directors shall forthwith proceed to convene a general
 meeting of Members within 60 days of receipt of the General Meeting Request ( ***General Meeting Request Period***). The General Meeting Request must state the objects of the
 meeting and must be signed by the Members requisitioning the meeting. The General Meeting
 Request must be lodged at the Registered Office and may be delivered in counterpart.

20.5 Without
 limitation to the foregoing, if there are insufficient Directors to constitute a quorum and
 the remaining Directors are unable to agree on the appointment of additional Directors, any
 one or more Members may call a general meeting for the purpose of considering the business
 specified in the General Meeting Request which shall include as an item of business the appointment
 of additional Directors.

20.6 If
 the Directors do not within the General Meeting Request Period proceed to convene a meeting
 of Members to be held within within 21 days of the General Meeting Request Period, the requisitionist,
 or any of them together holding at least half of the voting rights of all of them, may convene
 the meeting of Members in the same manner as nearly as possible as that in which a meeting
 of Members may be convened by a Director. Where the requisitionists fail to convene the meeting
 of Members within three months of their right to convene the meeting arising, the right to
 convene the meeting of Members shall lapse.

20.7 Members
 seeking to bring business before the annual general meeting or to nominate candidates for
 appointment as Directors at the annual general meeting must deliver notice to the principal
 executive offices of the Company not less than 120 calendar days before the date of the Company's
 proxy statement released to Members in connection with the previous year's annual general
 meeting or, if the Company did not hold an annual general meeting the previous year, or if
 the date of the current year's annual general meeting has been changed by more than
 30 days from the date of the previous year's annual general meeting, then the deadline
 shall be set by the board of Directors with such deadline being a reasonable time before
 the Company begins to print and send its related proxy materials.

---

| | |
|:---|:---|
| **21** | **Notice of General Meetings** |

---

21.1 At
 least 10 clear days' notice shall be given of any general meeting. Every notice shall
 specify the place, the day and the hour of the meeting and the general nature of the business
 to be conducted at the general meeting and shall be given in the manner hereinafter mentioned
 or in such other manner if any as may be prescribed by the Company, provided that a general
 meeting of the Company shall, whether or not the notice specified in this Article has been
 given and whether or not the provisions of the Articles regarding general meetings have been
 complied with, be deemed to have been duly convened if it is so agreed:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) in
 the case of an annual general meeting, by all of the Members entitled to attend and vote
 at the meeting; and

(b) in
 the case of an extraordinary general meeting, by a majority in number of the Members having
 a right to attend and vote at the meeting, together holding not less than 95% in par value
 of the Shares giving that right.

21.2 The
 accidental omission to give notice of a general meeting to, or the non receipt of notice
 of a general meeting by, any person entitled to receive such notice shall not invalidate
 the proceedings of that general meeting.

---

| | |
|:---|:---|
| **22** | **Proceedings at General Meetings** |

---

22.1 No
 business shall be transacted at any general meeting unless a quorum is present. The holders
 of not less than one third of votes attached to the Ordinary Shares being entitled to vote
 on resolutions of Members to be considered at the meeting, individuals present in person
 or by proxy or if a corporation or other non-natural person by its duly authorised representative
 or proxy shall be a quorum, except where there is only one Member entitled to vote on resolutions
 of Members to be considered at the meeting, in which case the quorum shall be one Member.

22.2 A
 person may participate at a general meeting by conference telephone or other communications
 equipment by means of which all the persons participating in the meeting can communicate
 with each other. Participation by a person in a general meeting in this manner is treated
 as presence in person at that meeting.

22.3 A
 resolution (including a Special Resolution) in writing (in one or more counterparts) signed
 by or on behalf of all of the Members for the time being entitled to receive notice of and
 to attend and vote at general meetings (or, being corporations or other non-natural persons,
 signed by their duly authorised representatives) shall be as valid and effective as if the
 resolution had been passed at a general meeting of the Company duly convened and held.

22.4 If
 a quorum is not present within half an hour from the time appointed for the meeting to commence,
 the meeting shall stand adjourned to the same day in the next week at the same time and/or
 place or to such other day, time and/or place as the Directors may determine, and shall be
 dissolved if convened upon by requisition of the Members.

22.5 The
 Directors may, at any time prior to the time appointed for the meeting to commence, appoint
 any person to act as chairperson of a general meeting of the Company or, if the Directors
 do not make any such appointment, the chairperson, if any, of the board of Directors shall
 preside as chairperson at such general meeting. If there is no such chairperson, or if the
 person shall not be present within 15 minutes after the time appointed for the meeting to
 commence, or is unwilling to act, the Directors present shall elect one of their number to
 be chairperson of the meeting.

22.6 If
 no Director is willing to act as chairperson or if no Director is present within 15 minutes
 after the time appointed for the meeting to commence, the Members present shall choose one
 of their number to be chairperson of the meeting.

22.7 The
 chairperson may, with the consent of a meeting at which a quorum is present (and shall if
 so directed by the meeting) adjourn the meeting from time to time and from place to place,
 but no business shall be transacted at any adjourned meeting other than the business left
 unfinished at the meeting from which the adjournment took place.

22.8 When
 a general meeting is adjourned for 30 days or more, notice of the adjourned meeting shall
 be given as in the case of an original meeting. Otherwise it shall not be necessary to give
 any such notice of an adjourned meeting.

22.9 A
 resolution put to the vote of the meeting shall be decided on a poll.

22.10 A
 poll shall be taken as the chairperson directs, and the result of the poll shall be deemed
 to be the resolution of the general meeting at which the poll was demanded.

22.11 A
 poll demanded on the election of a chairperson or on a question of adjournment shall be taken
 forthwith. A poll demanded on any other question shall be taken at such date, time and place
 as the chairperson of the general meeting directs, and any business other than that upon
 which a poll has been demanded or is contingent thereon may proceed pending the taking of
 the poll.

22.12 In
 the case of an equality of votes the chairperson shall be entitled to a second or casting
 vote.

---

| | |
|:---|:---|
| **23** | **Votes of Members** |

---

23.1 Subject
 to any rights or restrictions attached to any Shares (including, for the avoidance of doubt,
 the restrictions attached to the Series A Preferred Shares set out at Paragraph 3.1 of the
 Schedule) each Member present in person, by its duly authorised representative or by proxy,
 shall have one vote and on a poll each Member shall have one vote for every Share of which
 he is the holder.

23.2 In
 the case of joint holders the vote of the senior holder who tenders a vote, whether in person
 or by proxy (or, in the case of a corporation or other non-natural person, by its duly authorised
 representative or proxy), shall be accepted to the exclusion of the votes of the other joint
 holders, and seniority shall be determined by the order in which the names of the holders
 stand in the Register of Members.

23.3 A
 Member of unsound mind, or in respect of whom an order has been made by any court, having
 jurisdiction in lunacy, may vote by their committee, receiver, curator bonis, or other person
 on such Member's behalf appointed by that court, and any such committee, receiver,
 curator bonis or other person may vote by proxy.

23.4 No
 person shall be entitled to vote at any general meeting unless they are registered as a Member
 on the record date for such meeting nor unless all calls or other monies then payable by
 them in respect of Shares have been paid.

23.5 No
 objection shall be raised as to the qualification of any voter except at the general meeting
 or adjourned general meeting at which the vote objected to is given or tendered and every
 vote not disallowed at the meeting shall be valid. Any objection made in due time in accordance
 with this Article shall be referred to the chairperson whose decision shall be final and
 conclusive.

23.6 Votes
 may be cast either personally or by proxy (or in the case of a corporation or other non-natural
 person by its duly authorised representative or proxy). A Member may appoint more than one
 proxy or the same proxy under one or more instruments to attend and vote at a meeting and
 speak thereat on the Member's behalf. Where a Member appoints more than one proxy the
 instrument of proxy shall specify the number of Shares in respect of which each proxy is
 entitled to exercise the related votes.

23.7 A
 Member holding more than one Ordinary Share need not cast the votes in respect of their Shares
 in the same way on any resolution and therefore may vote a Share or some or all such Shares
 either for or against a resolution and/or abstain from voting a Share or some or all of the
 Shares and, subject to the terms of the instrument appointing the proxy, a proxy appointed
 under one or more instruments may vote a Share or some or all of the Shares in respect of
 which they are appointed either for or against a resolution and/or abstain from voting a
 Share or some or all of the Shares in respect of which they are appointed.

---

| | |
|:---|:---|
| **24** | **Proxies** |

---

24.1 The
 instrument appointing a proxy shall be in writing and shall be executed under the hand of
 the appointor or of their attorney duly authorised in writing, or, if the appointor is a
 corporation or other non natural person, under the hand of its duly authorised representative.
 A proxy need not be a Member.

24.2 The
 Directors may, in the notice convening any meeting or adjourned meeting, or in an instrument
 of proxy sent out by the Company, specify the manner by which the instrument appointing a
 proxy shall be deposited and the place and the time (being not later than the time appointed
 for the commencement of the meeting or adjourned meeting to which the proxy relates) at which
 the instrument appointing a proxy shall be deposited. In the absence of any such direction
 from the Directors in the notice convening any meeting or adjourned meeting or in an instrument
 of proxy sent out by the Company, the instrument appointing a proxy shall be deposited physically
 at the Registered Office not less than 48 hours before the time appointed for the meeting
 or adjourned meeting to commence at which the person named in the instrument proposes to
 vote.

24.3 The
 chairperson may in any event at their discretion declare that an instrument of proxy shall
 be deemed to have been duly deposited. An instrument of proxy that is not deposited in the
 manner permitted, or which has not been declared to have been duly deposited by the chairperson,
 shall be invalid.

24.4 The
 instrument appointing a proxy may be in any usual or common form (or such other form as the
 Directors may approve) and may be expressed to be for a particular meeting or any adjournment
 thereof or generally until revoked. An instrument appointing a proxy shall be deemed to include
 the power to demand or join or concur in demanding a poll.

24.5 Votes
 given in accordance with the terms of an instrument of proxy shall be valid notwithstanding
 the previous death or insanity of the principal or revocation of the proxy or of the authority
 under which the proxy was executed, or the transfer of the Share in respect of which the
 proxy is given unless notice in writing of such death, insanity, revocation or transfer was
 received by the Company at the Registered Office before the commencement of the general meeting,
 or adjourned meeting at which it is sought to use the proxy.

---

| | |
|:---|:---|
| **25** | **Corporate Members** |

---

25.1 Any
 corporation or other non-natural person which is a Member may in accordance with its constitutional
 documents, or in the absence of such provision by resolution of its directors or other governing
 body, authorise such person as it thinks fit to act as its representative at any meeting
 of the Company or of any class of Members, and the person so authorised shall be entitled
 to exercise the same powers on behalf of the corporation which they represent as the corporation
 could exercise if it were an individual Member.

25.2 If
 a Clearing House (or its nominee(s)), being a corporation, is a Member, it may authorise
 such persons as it sees fit to act as its representative at any meeting of the Company or
 at any meeting of any class of Members provided that the authorisation shall specify the
 number and class or series of Shares in respect of which each such representative is so authorised.
 Each person so authorised under the provisions of this Article shall be deemed to have been
 duly authorised without further evidence of the facts and be entitled to exercise the same
 rights and powers on behalf of the Clearing House (or its nominee(s)) as if such person was
 the registered holder of such Shares held by the Clearing House (or its nominee(s)).

---

| | |
|:---|:---|
| **26** | **Shares that May Not be Voted** |

---

Shares in the Company that are beneficially owned by the Company shall not be voted, directly or indirectly, at any meeting and shall not be counted in determining the total number of outstanding Shares at any given time.

---

| | |
|:---|:---|
| **27** | **Directors** |

---

27.1 There
 shall be a board of Directors consisting of not less than two persons (exclusive of alternate
 Directors) provided however that the Company may by Ordinary Resolution increase or reduce
 the limits in the number of Directors.

27.2 Except
 as the Statute or other Applicable Law may otherwise require, in the interim between annual
 general meetings or extraordinary general meetings called for the appointment of Directors
 and/or the removal of one or more Directors and the filling of any vacancy in that connection,
 additional Directors and any vacancies in the board of Directors, including unfilled vacancies
 resulting from the removal of Directors for cause, may be filled by the vote of a majority
 of the remaining Directors then in office, although less than a quorum (as defined in the
 Articles), or by the sole remaining Director. All Directors shall hold office until the expiration
 of their respective terms of office and until their successors shall have been appointed
 and qualified. A Director appointed to fill a vacancy resulting from the death, resignation
 or removal of a Director shall serve for the remainder of the full term of the Director whose
 death, resignation or removal shall have created such vacancy and until their successor shall
 have been appointed and qualified.

---

| | |
|:---|:---|
| **28** | **Powers of Directors** |

---

28.1 Subject
 to the provisions of the Statute, the Memorandum and the Articles and to any directions given
 by Special Resolution, the business of the Company shall be managed by the Directors who
 may exercise all the powers of the Company. No alteration of the Memorandum or Articles and
 no such direction shall invalidate any prior act of the Directors which would have been valid
 if that alteration had not been made or that direction had not been given. A duly convened
 meeting of Directors at which a quorum is present may exercise all powers exercisable by
 the Directors.

28.2 All
 cheques, promissory notes, drafts, bills of exchange and other negotiable or transferable
 instruments and all receipts for monies paid to the Company shall be signed, drawn, accepted,
 endorsed or otherwise executed as the case may be in such manner as the Directors shall determine
 by resolution.

28.3 The
 Directors on behalf of the Company may pay a gratuity or pension or allowance on retirement
 to any Director who has held any other salaried office or place of profit with the Company
 or to their surviving spouse, civil partner or dependants and may make contributions to any
 fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance.

28.4 The
 Directors may exercise all the powers of the Company to borrow money and to mortgage or charge
 its undertaking, property and assets (present and future) and uncalled capital or any part
 thereof and to issue debentures, debenture stock, mortgages, bonds and other such securities
 whether outright or as security for any debt, liability or obligation of the Company or of
 any third party.

---

| | |
|:---|:---|
| **29** | **Appointment and Removal of Directors** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29.1 The
 Company may by Ordinary Resolution appoint any person to be a Director or may by Ordinary
 Resolution remove any Director.

29.2 A
 Director may also be removed by notice in writing signed by not less than 75% of the Directors
 in office.

29.3 The
 Directors may appoint any person to be a Director, either to fill a vacancy or as an additional
 Director provided that the appointment does not cause the number of Directors to exceed any
 number fixed by or in accordance with the Articles as the maximum number of Directors.

---

| | |
|:---|:---|
| **30** | **Vacation of Office of Director** |

---

The office of a Director shall be vacated if:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the
 Director gives notice in writing to the Company that they resign the office of Director;
 or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the
 Director is absent (for the avoidance of doubt, without being represented by proxy or an
 alternate Director appointed by them) from three consecutive meetings of the board of Directors
 without special leave of absence from the Directors, and the Directors pass a resolution
 that they have by reason of such absence vacated office; or

(c) the
 Director dies, becomes bankrupt or makes any arrangement or composition with their creditors
 generally; or

(d) the
 Director is found to be or becomes of unsound mind; or

(e) all
 of the other Directors (being not less than two in number) determine that the Director should
 be removed as a Director, either by a resolution passed by all of the other Directors at
 a meeting of the Directors duly convened and held in accordance with the Articles or by a
 resolution in writing signed by 75% of the other Directors.

---

| | |
|:---|:---|
| **31** | **Proceedings of Directors** |

---

31.1 The
 quorum for the transaction of the business of the Directors may be fixed by the Directors,
 and unless so fixed shall be a majority of Directors (and shall be one Director in the event
 there is only one Director in office). A person who holds office as an alternate Director
 shall, if their appointor is not present, be counted in the quorum. A Director who also acts
 as an alternate Director shall, if their appointor is not present, count twice towards the
 quorum.

31.2 Subject
 to the provisions of the Articles, the Directors may regulate their proceedings as they think
 fit. Questions arising at any meeting shall be decided by a majority of votes. In the case
 of an equality of votes, the chairperson shall have a second or casting vote. A Director
 who is also an alternate Director shall be entitled in the absence of their appointor to
 a separate vote on behalf of their appointor in addition to their own vote.

31.3 A
 person may participate in a meeting of the Directors or any committee of Directors by conference
 telephone or other communications equipment by means of which all the persons participating
 in the meeting can communicate with each other at the same time. Participation by a person
 in a meeting in this manner is treated as presence in person at that meeting. Unless otherwise
 determined by the Directors, the meeting shall be deemed to be held at the place where the
 chairperson is located at the start of the meeting.

31.4 A
 resolution in writing (in one or more counterparts) signed by all the Directors or all the
 members of a committee of the Directors or, in the case of a resolution in writing relating
 to the removal of any Director or the vacation of office by any Director, all of the Directors
 other than the Director who is the subject of such resolution (an alternate Director being
 entitled to sign such a resolution on behalf of their appointor and if such alternate Director
 is also a Director, being entitled to sign such resolution both on behalf of their appointor
 and in their capacity as a Director) shall be as valid and effectual as if it had been passed
 at a meeting of the Directors, or committee of Directors as the case may be, duly convened
 and held.

31.5 A
 Director or alternate Director may, or other officer of the Company on the direction of a Director or alternate Director shall, call
 a meeting of the Directors by at least two days' notice in writing to every Director and alternate Director which notice shall
 set forth the general nature of the business to be considered unless notice is waived by all the Directors (or their alternates)
 either at, before or after the meeting is held. To any such notice of a meeting of the Directors all the provisions of the Articles
 relating to the giving of notices by the Company to the Members shall apply *mutatis mutandis.* 

31.6 The
 continuing Directors (or a sole continuing Director, as the case may be) may act notwithstanding any vacancy in their body, but if
 and so long as their number is reduced below the number fixed by or pursuant to the Articles as the necessary quorum of Directors
 the continuing Directors or Director may act for the purpose of increasing the number of Directors to be equal to such fixed number,
 or of summoning a general meeting of the Company, but for no other purpose.

31.7 The
 Directors may elect a chairperson of their board and determine the period for which they are to hold office; but if no such chairperson
 is elected, or if at any meeting the chairperson is not present within five minutes after the time appointed for the meeting to commence,
 the Directors present may choose one of their number to be chairperson of the meeting.

31.8 All
 acts done by any meeting of the Directors or of a committee of the Directors (including any person acting as an alternate Director)
 shall, notwithstanding that it is afterwards discovered that there was some defect in the appointment of any Director or alternate
 Director, and/or that they or any of them were disqualified, and/or had vacated their office and/or were not entitled to vote, be
 as valid as if every such person had been duly appointed and/or not disqualified to be a Director or alternate Director and/or had
 not vacated their office and/or had been entitled to vote, as the case may be.

31.9 A
 Director but not an alternate Director may be represented at any meetings of the board of Directors by a proxy appointed in writing
 by that Director. The proxy shall count towards the quorum and the vote of the proxy shall for all purposes be deemed to be that
 of the appointing Director.

---

| | |
|:---|:---|
| **32** | **Presumption of Assent** |

---

A Director or alternate Director who is present at a meeting of the board of Directors at which action on any Company matter is taken shall be presumed to have assented to the action taken unless their dissent shall be entered in the minutes of the meeting or unless they shall file their written dissent from such action with the person acting as the chairperson or secretary of the meeting before the adjournment thereof or shall forward such dissent by registered post to such person immediately after the adjournment of the meeting. Such right to dissent shall not apply to a Director or alternate Director who voted in favour of such action.

---

| | |
|:---|:---|
| **33** | **Directors' Interests** |

---

33.1 A
 Director or alternate Director may hold any other office or place of profit under the Company (other than the office of Auditor)
 in conjunction with their office of Director for such period and on such terms as to remuneration and otherwise as the Directors
 may determine.

33.2 A
 Director or alternate Director may act on their own or by, through or on behalf of their firm in a professional capacity for the
 Company and they or their firm shall be entitled to remuneration for professional services as if they were not a Director or alternate
 Director.

33.3 A
 Director or alternate Director may be or become a director or other officer of or otherwise interested in any company promoted by
 the Company or in which the Company may be interested as a shareholder, a contracting party or otherwise, and no such Director or
 alternate Director shall be accountable to the Company for any remuneration or other benefits received by them as a director or officer
 of, or from their interest in, such other company.

33.4 No
 person shall be disqualified from the office of Director or alternate Director or prevented by such office from contracting with
 the Company, either as vendor, purchaser or otherwise, nor shall any such contract or any contract or transaction entered into by
 or on behalf of the Company in which any Director or alternate Director shall be in any way interested be or be liable to be avoided,
 nor shall any Director or alternate Director so contracting or being so interested be liable to account to the Company for any profit
 realised by or arising in connection with any such contract or transaction by reason of such Director or alternate Director holding
 office or of the fiduciary relationship thereby established. A Director (or their alternate Director in their absence) shall be at
 liberty to vote in respect of any contract or transaction in which they are interested provided that the nature of the interest of
 any Director or alternate Director in any such contract or transaction shall be disclosed by them at or prior to its consideration
 and any vote thereon.

33.5 A
 general notice that a Director or alternate Director is a shareholder, director, officer or employee of any specified firm or company
 and is to be regarded as interested in any transaction with such firm or company shall be sufficient disclosure for the purposes
 of voting on a resolution in respect of a contract or transaction in which they have an interest, and after such general notice it
 shall not be necessary to give special notice relating to any particular transaction.

---

| | |
|:---|:---|
| **34** | **Minutes** |

---

The Directors shall cause minutes to be made in books kept for the purpose of recording all appointments of officers made by the Directors, all proceedings at meetings of the Company or the holders of any class of Shares and of the Directors, and of committees of the Directors, including the names of the Directors or alternate Directors present at each meeting.

---

| | |
|:---|:---|
| **35** | **Delegation of Directors' Powers** |

---

35.1 The
 Directors may delegate any of their powers, authorities and discretions, including the power to sub-delegate, to any committee consisting
 of one or more Directors (including, without limitation, the Audit Committee, the Compensation Committee and the Nominating and Corporate
 Governance Committee). They may also delegate to any managing director or any Director holding any other executive office such of
 their powers, authorities and discretions as they consider desirable to be exercised by that Director, provided that an alternate
 Director may not act as managing director and the appointment of a managing director shall be revoked forthwith if they cease to
 be a Director. Any such delegation may be made subject to any conditions the Directors may impose and either collaterally with or
 to the exclusion of their own powers and any such delegation may be revoked or altered by the Directors. Subject to any such conditions,
 the proceedings of a committee of Directors shall be governed by the Articles regulating the proceedings of Directors, so far as
 they are capable of applying.

35.2 The
 Directors may establish any committees, local boards or agencies or appoint any person to be a manager or agent for managing the
 affairs of the Company and may appoint any person to be a member of such committees, local boards or agencies. Any such appointment
 may be made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion of their own powers
 and any such appointment may be revoked or altered by the Directors. Subject to any such conditions, the proceedings of any such
 committee, local board or agency shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable
 of applying.

35.3 The
 Directors may adopt formal written charters for committees as may be required from time to time by the rules and regulations of the
 Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under
 Applicable Law. Each of these committees shall be empowered to do all things necessary to exercise the rights of such committee set
 forth in the Articles and shall have such powers as the Directors may delegate pursuant to the Articles and as required by the rules
 and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority
 or otherwise under Applicable Law. Each of the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance
 Committee, if established, shall consist of such number of Directors as the Directors shall from time to time determine (or such
 minimum number as may be required from time to time by the rules and regulations of the Designated Stock Exchange, the Securities
 and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law). For so long as any class
 or series of Shares is listed on the Designated Stock Exchange, the Audit Committee, the Compensation Committee and the Nominating
 and Corporate Governance Committee shall be made up of such number of Independent Directors as is required from time to time by the
 rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory
 authority or otherwise under Applicable Law.

35.4 The
 Directors may by power of attorney or otherwise appoint any person to be the agent of the Company on such conditions as the Directors
 may determine, provided that the delegation is not to the exclusion of their own powers and may be revoked by the Directors at any
 time.

35.5 The
 Directors may by power of attorney or otherwise appoint any company, firm, person or body of persons, whether nominated directly
 or indirectly by the Directors, to be the attorney or authorised signatory of the Company for such purpose and with such powers,
 authorities and discretions (not exceeding those vested in or exercisable by the Directors under the Articles) and for such period
 and subject to such conditions as they may think fit, and any such powers of attorney or other appointment may contain such provisions
 for the protection and convenience of persons dealing with any such attorneys or authorised signatories as the Directors may think
 fit and may also authorise any such attorney or authorised signatory to delegate all or any of the powers, authorities and discretions
 vested in them.

35.6 The
 Directors may appoint such Officers as they consider necessary on such terms, at such remuneration and to perform such duties, and
 subject to such provisions as to disqualification and removal as the Directors may think fit. Unless otherwise specified in the terms
 of their appointment an Officer may be removed by resolution of the Directors or Members. An Officer may vacate their office at any
 time if they give notice in writing to the Company that they resign their office.

---

| | |
|:---|:---|
| **36** | **Alternate Directors** |

---

36.1 Any
 Director (but not an alternate Director) may by writing appoint any other Director, or any other person willing to act, to be an
 alternate Director and by writing may remove from office an alternate Director so appointed by them.

36.2 An
 alternate Director shall be entitled to receive notice of all meetings of Directors and of all meetings of committees of Directors
 of which their appointor is a member, to attend and vote at every such meeting at which the Director appointing them is not personally
 present, to sign any written resolution of the Directors, and generally to perform all the functions of their appointor as a Director
 in their absence.

36.3 An
 alternate Director shall cease to be an alternate Director if their appointor ceases to be a Director.

36.4 Any
 appointment or removal of an alternate Director shall be by notice to the Company signed by the Director making or revoking the appointment
 or in any other manner approved by the Directors.

36.5 Subject
 to the provisions of the Articles, an alternate Director shall be deemed for all purposes to be a Director and shall alone be responsible
 for their own acts and defaults and shall not be deemed to be the agent of the Director appointing them.

---

| | |
|:---|:---|
| **37** | **No Minimum Shareholding** |

---

The Company in a general meeting may fix a minimum shareholding required to be held by a Director, but unless and until such a shareholding qualification is fixed a Director is not required to hold Shares.

---

| | |
|:---|:---|
| **38** | **Remuneration of Directors** |

---

38.1 The
 remuneration to be paid to the Directors, if any, shall be such remuneration as the Directors shall determine. The Directors shall
 also be entitled to be paid all travelling, hotel and other expenses properly incurred by them in connection with their attendance
 at meetings of Directors or committees of Directors, or general meetings of the Company, or separate meetings of the holders of any
 class or series of Shares or debentures of the Company, or otherwise in connection with the business of the Company or the discharge
 of their duties as a Director, or to receive a fixed allowance in respect thereof as may be determined by the Directors, or a combination
 partly of one such method and partly the other.

38.2 The
 Directors may by resolution approve additional remuneration to any Director for any services which in the opinion of the Directors
 go beyond that Director's ordinary routine work as a Director. Any fees paid to a Director who is also counsel, attorney or
 solicitor to the Company, or otherwise serves it in a professional capacity shall be in addition to their remuneration as a Director.

---

| | |
|:---|:---|
| **39** | **Seal** |

---

39.1 The
 Company may, if the Directors so determine, have a Seal. The Seal shall only be used by the authority of the Directors or of a committee
 of the Directors authorised by the Directors. Every instrument to which the Seal has been affixed shall be signed by at least one
 person who shall be either a Director or some Officer or other person appointed by the Directors for the purpose.

39.2 The
 Company may have for use in any place or places outside the Cayman Islands a duplicate Seal or Seals each of which shall be a facsimile
 of the common Seal of the Company and, if the Directors so determine, with the addition on its face of the name of every place where
 it is to be used.

39.3 A
 Director or Officer, representative or attorney of the Company may without further authority of the Directors affix the Seal over
 their signature alone to any document of the Company required to be authenticated by them under seal or to be filed with the Registrar
 of Companies in the Cayman Islands or elsewhere wheresoever.

---

| | |
|:---|:---|
| **40** | **Dividends, Distributions and Reserve** |

---

40.1 Subject
 to the Statute and this Article and except as otherwise provided by the rights attached to any Shares, the Directors may resolve
 to pay Dividends and other distributions on Shares in issue and authorise payment of the Dividends or other distributions out of
 the funds of the Company lawfully available therefor. A Dividend shall be deemed to be an interim Dividend unless the terms of the
 resolution pursuant to which the Directors resolve to pay such Dividend specifically state that such Dividend shall be a final Dividend.
 No Dividend or other distribution shall be paid except out of the realised or unrealised profits of the Company, out of the share
 premium account or as otherwise permitted by law.

40.2 Except
 as otherwise provided by the rights attached to any Shares, all Dividends and other distributions shall be paid according to the
 par value of the Shares that a Member holds. If any Share is issued on terms providing that it shall rank for Dividend as from a
 particular date, that Share shall rank for Dividend accordingly.

40.3 The
 Directors may deduct from any Dividend or other distribution payable to any Member all sums of money (if any) then payable by the
 Member to the Company on account of calls or otherwise.

40.4 The
 Directors may resolve that any Dividend or other distribution be paid wholly or partly by the distribution of specific assets and
 in particular (but without limitation) by the distribution of shares, debentures, or securities of any other company or in any one
 or more of such ways and where any difficulty arises in regard to such distribution, the Directors may settle the same as they think
 expedient and in particular may issue fractional Shares and may fix the value for distribution of such specific assets or any part
 thereof and may determine that cash payments shall be made to any Members upon the basis of the value so fixed in order to adjust
 the rights of all Members and may vest any such specific assets in trustees in such manner as may seem expedient to the Directors.

40.5 Except
 as otherwise provided by the rights attached to any Shares, Dividends and other distributions may be paid in any currency. The Directors
 may determine the basis of conversion for any currency conversions that may be required and how any costs involved are to be met.

40.6 The
 Directors may, before resolving to pay any Dividend or other distribution, set aside such sums as they think proper as a reserve
 or reserves which shall, at the discretion of the Directors, be applicable for any purpose of the Company and pending such application
 may, at the discretion of the Directors, be employed in the business of the Company.

40.7 Any
 Dividend, other distribution, interest or other monies payable in cash in respect of Shares may be paid by wire transfer to the holder
 or by cheque or warrant sent through the post directed to the registered address of the holder or, in the case of joint holders,
 to the registered address of the holder who is first named on the Register of Members or to such person and to such address as such
 holder or joint holders may in writing direct. Every such cheque or warrant shall be made payable to the order of the person to whom
 it is sent. Any one of two or more joint holders may give effectual receipts for any Dividends, other distributions, bonuses, or
 other monies payable in respect of the Share held by them as joint holders.

40.8 No
 Dividend or other distribution shall bear interest against the Company.

40.9 Any
 Dividend or other distribution which cannot be paid to a Member and/or which remains unclaimed after six months from the date on
 which such Dividend or other distribution becomes payable may, in the discretion of the Directors, be paid into a separate account
 in the Company's name, provided that the Company shall not be constituted as a trustee in respect of that account and the Dividend
 or other distribution shall remain as a debt due to the Member. Any Dividend or other distribution which remains unclaimed after
 a period of six years from the date on which such Dividend or other distribution becomes payable shall be forfeited and shall revert
 to the Company.

---

| | |
|:---|:---|
| **41** | **Capitalisation** |

---

The Directors may at any time capitalise any sum standing to the credit of any of the Company's reserve accounts or funds (including the share premium account and capital redemption reserve fund) or any sum standing to the credit of the profit and loss account or otherwise available for distribution; appropriate such sum to Members in the proportions in which such sum would have been divisible amongst such Members had the same been a distribution of profits by way of Dividend or other distribution; and apply such sum on their behalf in paying up in full unissued Shares for allotment and distribution credited as fully paid-up to and amongst them in the proportion aforesaid. In such event the Directors shall do all acts and things required to give effect to such capitalisation, with full power given to the Directors to make such provisions as they think fit in the case of Shares becoming distributable in fractions (including provisions whereby the benefit of fractional entitlements accrue to the Company rather than to the Members concerned). The Directors may authorise any person to enter on behalf of all of the Members interested into an agreement with the Company providing for such capitalisation and matters incidental or relating thereto and any agreement made under such authority shall be effective and binding on all such Members and the Company.

---

| | |
|:---|:---|
| **42** | **Books of Account** |

---

42.1 The
 Directors shall cause proper books of account (including, where applicable, material underlying documentation including contracts
 and invoices) to be kept with respect to all sums of money received and expended by the Company and the matters in respect of which
 the receipt or expenditure takes place, all sales and purchases of goods by the Company and the assets and liabilities of the Company.
 Such books of account must be retained for a minimum period of five years from the date on which they are prepared. Proper books
 shall not be deemed to be kept if there are not kept such books of account as are necessary to give a true and fair view of the state
 of the Company's affairs and to explain its transactions.

42.2 The
 Directors shall determine whether and to what extent and at what times and places and under what conditions or regulations the accounts
 and books of the Company or any of them shall be open to the inspection of Members not being Directors and no Member (not being a
 Director) shall have any right of inspecting any account or book or document of the Company except as conferred by Statute or authorised
 by the Directors or by the Company in general meeting.

42.3 The
 Directors may cause to be prepared and to be laid before the Company in general meeting profit and loss accounts, balance sheets,
 group accounts (if any) and such other reports and accounts as may be required by law.

---

| | |
|:---|:---|
| **43** | **Audit** |

---

43.1 The
 Directors may appoint an Auditor of the Company who shall hold office on such terms as the Directors determine.

43.2 Without
 prejudice to the freedom of the Directors to establish any other committee, if the Shares (or depositary receipts therefor) are listed
 or quoted on the Designated Stock Exchange, and if required by the rules and regulations of the Designated Stock Exchange, the Securities
 and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law, the Directors shall establish
 and maintain an Audit Committee as a committee of the Directors and shall adopt a formal written Audit Committee charter and review
 and assess the adequacy of the formal written charter on an annual basis. The composition and responsibilities of the Audit Committee
 shall comply with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other
 competent regulatory authority or otherwise under Applicable Law. If the Shares (or depositary receipts therefor) are listed or quoted
 on the Designated Stock Exchange, the Company shall conduct an appropriate review of all related party transactions on an ongoing
 basis and shall utilise the Audit Committee for the review and approval of potential conflicts of interest.

43.3 The
 remuneration of the Auditor shall be fixed by the Audit Committee (if one exists).

43.4 If
 the office of Auditor becomes vacant by resignation or death of the Auditor, or by their becoming incapable of acting by reason of
 illness or other disability at a time when their services are required, the Directors shall fill the vacancy and determine the remuneration
 of such Auditor.

43.5 Every
 Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers of the Company and shall
 be entitled to require from the Directors and Officers such information and explanation as may be necessary for the performance of
 the duties of the Auditor.

43.6 Auditors
 shall, if so required by the Directors, make a report on the accounts of the Company during their tenure of office at the next annual
 general meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an ordinary
 company, and at the next extraordinary general meeting following their appointment in the case of a company which is registered with
 the Registrar of Companies as an exempted company, and at any other time during their term of office, upon request of the Directors
 or any general meeting of the Members.

43.7 At
 least one member of the Audit Committee shall be an "audit committee financial expert" as determined by the rules and
 regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority
 or otherwise under Applicable Law. The "audit committee financial expert" shall have such past employment experience
 in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which
 results in the individual's financial sophistication.

---

| | |
|:---|:---|
| **44** | **Notices** |

---

44.1 Notices
 shall be in writing and may be given by the Company to any Member either personally or by sending it by courier, post, telex, fax
 or email to such Member or to such Member's address as shown in the Register of Members (or where the notice is given by email
 by sending it to the email address provided by such Member). Notice may also be served by Electronic Communication in accordance
 with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent
 regulatory authority or by placing it on the Company's Website.

44.2 Where
 a notice is sent by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) courier;
 service of the notice shall be deemed to be effected by delivery of the notice to a courier company, and shall be deemed to have
 been received on the third day (not including Saturdays or Sundays or public holidays) following the day on which the notice was
 delivered to the courier;

(b) post;
 service of the notice shall be deemed to be effected by properly addressing, pre paying and posting a letter containing the notice,
 and shall be deemed to have been received on the fifth day (not including Saturdays or Sundays or public holidays in the Cayman Islands)
 following the day on which the notice was posted;

(c) telex
 or fax; service of the notice shall be deemed to be effected by properly addressing and sending such notice and shall be deemed to
 have been received on the same day that it was transmitted;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) email
 or other Electronic Communication; service of the notice shall be deemed to be effected by transmitting the email to the email address
 provided by the intended recipient and shall be deemed to have been received on the same day that it was sent, and it shall not be
 necessary for the receipt of the email to be acknowledged by the recipient; and

(e) placing
 it on the Company's Website; service of the notice shall be deemed to have been effected one hour after the notice or document
 was placed on the Company's Website.

44.3 A
 notice may be given by the Company to the person or persons which the Company has been advised are entitled to a Share or Shares
 in consequence of the death or bankruptcy of a Member in the same manner as other notices which are required to be given under the
 Articles and shall be addressed to them by name, or by the title of representatives of the deceased, or trustee of the bankrupt,
 or by any like description at the address supplied for that purpose by the persons claiming to be so entitled, or at the option of
 the Company by giving the notice in any manner in which the same might have been given if the death or bankruptcy had not occurred.

44.4 Notice
 of every general meeting shall be given in any manner authorised by the Articles to every holder of Shares carrying an entitlement
 to receive such notice on the record date for such meeting except that in the case of joint holders the notice shall be sufficient
 if given to the joint holder first named in the Register of Members and every person upon whom the ownership of a Share devolves
 because they are a legal personal representative or a trustee in bankruptcy of a Member where the Member but for their death or bankruptcy
 would be entitled to receive notice of the meeting, and no other person shall be entitled to receive notices of general meetings.

---

| | |
|:---|:---|
| **45** | **Winding Up** |

---

45.1 If
 the Company shall be wound up, the liquidator shall apply the assets of the Company in satisfaction of creditors' claims in
 such manner and order as such liquidator thinks fit. Subject to the rights attaching to any Shares, in a winding up:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) if
 the assets available for distribution amongst the Members shall be insufficient to repay the whole of the Company's issued
 share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the Members in proportion
 to the par value of the Shares held by them; or

(b) if
 the assets available for distribution amongst the Members shall be more than sufficient to repay the whole of the Company's
 issued share capital at the commencement of the winding up, the surplus shall be distributed amongst the Members in proportion to
 the par value of the Shares held by them at the commencement of the winding up subject to a deduction from those Shares in respect
 of which there are monies due, of all monies payable to the Company for unpaid calls or otherwise.

45.2 If
 the Company shall be wound up the liquidator may, subject to the rights attaching to any Shares and with the approval of a Special
 Resolution of the Company and any other approval required by the Statute, divide amongst the Members in kind the whole or any part
 of the assets of the Company (whether such assets shall consist of property of the same kind or not) and may for that purpose value
 any assets and determine how the division shall be carried out as between the Members or different classes of Members. The liquidator
 may, with the like approval, vest the whole or any part of such assets in trustees upon such trusts for the benefit of the Members
 as the liquidator, with the like approval, shall think fit, but so that no Member shall be compelled to accept any asset upon which
 there is a liability.

---

| | |
|:---|:---|
| **46** | **Indemnity and Insurance** |

---

46.1 Every
 Director and Officer (which for the avoidance of doubt, shall not include auditors of the Company), together with every former Director
 and former Officer (each an  ***Indemnified Person***) shall be indemnified out of the assets of the Company against any liability,
 action, proceeding, claim, demand, costs, damages or expenses, including legal expenses, whatsoever which they or any of them may
 incur as a result of any act or failure to act in carrying out their functions other than such liability (if any) that they may incur
 by reason of their own actual fraud, wilful neglect or wilful default. No Indemnified Person shall be liable to the Company for any
 loss or damage incurred by the Company as a result (whether direct or indirect) of the carrying out of their functions unless that
 liability arises through the actual fraud, wilful neglect or wilful default of such Indemnified Person. No person shall be found
 to have committed actual fraud, wilful neglect or wilful default under this Article unless or until a court of competent jurisdiction
 shall have made a finding to that effect.

46.2 The
 Company shall advance to each Indemnified Person reasonable attorneys' fees and other costs and expenses incurred in connection
 with the defence of any action, suit, proceeding or investigation involving such Indemnified Person for which indemnity will or could
 be sought. In connection with any advance of any expenses hereunder, the Indemnified Person shall execute an undertaking to repay
 the advanced amount to the Company if it shall be determined by final judgment or other final adjudication that such Indemnified
 Person was not entitled to indemnification pursuant to this Article. If it shall be determined by a final judgment or other final
 adjudication that such Indemnified Person was not entitled to indemnification with respect to such judgment, costs or expenses, then
 such party shall not be indemnified with respect to such judgment, costs or expenses and any advancement shall be returned to the
 Company (without interest) by the Indemnified Person.

46.3 The
 Directors, on behalf of the Company, may purchase and maintain insurance for the benefit of any Director or Officer against any liability
 which, by virtue of any rule of law, would otherwise attach to such person in respect of any negligence, default, breach of duty
 or breach of trust of which such person may be guilty in relation to the Company.

---

| | |
|:---|:---|
| **47** | **Financial Year** |

---

Unless the Directors otherwise prescribe, the financial year of the Company shall end on 31st July in each year and, following the year of incorporation, shall begin on 1st Augustin each year.

---

| | |
|:---|:---|
| **48** | **Transfer by Way of Continuation** |

---

If the Company is exempted as defined in the Statute, it shall, subject to the provisions of the Statute and with the approval of a Special Resolution, have the power to register by way of continuation as a body corporate under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.

---

| | |
|:---|:---|
| **49** | **Mergers and Consolidations** |

---

The Company shall have the power to merge or consolidate with one or more other constituent companies (as defined in the Statute) upon such terms as the Directors may determine and (to the extent required by the Statute) with the approval of a Special Resolution.

---

| | |
|:---|:---|
| **50** | **Exclusive Jurisdiction and Forum** |

---

50.1 Unless
 the Company consents in writing to the selection of an alternative forum, the courts of the Cayman Islands shall have exclusive jurisdiction
 over any claim or dispute arising out of or in connection with the Memorandum, the Articles or otherwise related in any way to each
 Member's shareholding in the Company, including but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any
 derivative action or proceeding brought on behalf of the Company;

(b) any
 action asserting a claim of breach of any fiduciary or other duty owed by any current or former Director, Officer or other employee
 of the Company to the Company or the Members;

(c) any
 action asserting a claim arising pursuant to any provision of the Statute, the Memorandum or the Articles; or

(d) any
 action asserting a claim against the Company governed by the "Internal Affairs Doctrine" (as such concept is recognised
 under the laws of the United States of America).

50.2 Each
 Member irrevocably submits to the exclusive jurisdiction of the courts of the Cayman Islands over all such claims or disputes.

50.3 Without
 prejudice to any other rights or remedies that the Company may have, each Member acknowledges that damages alone would not be an
 adequate remedy for any breach of the selection of the courts of the Cayman Islands as exclusive forum and that accordingly the Company
 shall be entitled, without proof of special damages, to the remedies of injunction, specific performance or other equitable relief
 for any threatened or actual breach of the selection of the courts of the Cayman Islands as exclusive forum.

50.4 This

 Act of 1933, as amended, the Exchange Act, or any claim for which the federal district courts of the United States of America are,
 as a matter of the laws of the United States, the sole and exclusive forum for determination of such a claim.

**Schedule to Articles of Association**

**Schedule - Series A Preferred Shares**

For and as long as there are Series A Preferred Shares issued and outstanding in the capital of the Company, the rights, restrictions and limitations set out in the following provisions of this Schedule shall apply to such Series A Preferred Shares.

---

| | |
|:---|:---|
| **1** | **Interpretation** |

---

1.1 In
 this Schedule unless there is something in the subject or context inconsistent therewith:

---

| | |
|:---|:---|
| ***"Affiliate"*** <br>| means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act. |
| <br> *"**Beneficial Ownership Limitation**"*  | <br> means 9.99% of the number of Ordinary Shares outstanding immediately following the closing of the Business Combination.<br>|
| "***Business Day***" | means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York or Cayman Islands are authorised or required by law or other governmental action to close.<br>|
| "***Closing Date"*** | has the meaning given in the Merger and Contribution Agreement.<br>|
| "***Commission****"* | means the United States Securities and Exchange Commission.<br>|
| ***"Conversion Amount"***<br>| means the sum of the Stated Value at issue. |
| ***"Conversion Date"*** <br>| has the meaning given in Paragraph 4.1.<br>|
| *"**Conversion Price**"* <br>| has the meaning given in Paragraph 4.2. |
| ***"Conversion Shares"***  | means, collectively, the Ordinary Shares issuable upon conversion of the shares of Series A Preferred Shares in accordance with the terms of these Articles. |

---

---

| | |
|:---|:---|
| *"**Fundamental Transaction**"* <br>| has the meaning given in Paragraph 5.4. |
| ***"Notice of Conversion"*** | has the meaning given in Paragraph 4.1.<br>|
| ***"Ordinary Share Equivalents"*** | means any securities of the Company which would entitle the holder thereof to acquire at any time Ordinary Shares, including, without limitation, any debt, preferred shares, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary Shares. |
| <br> ***"Original Issue Date"*** | <br> means the date of the first issuance of any Series A Preferred Shares regardless of the number of transfers of any particular Series A Preferred Shares and regardless of the number of certificates which may be issued to evidence such Series A Preferred Shares.<br>|
| ***"Person"*** | means an individual or company, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.<br>|
| ***"Series A Preferred Shares"*** | means the series A convertible preferred shares of $0.001 par value each.<br>|
| ***"Series A Preferred Shareholder"***<br>| means a holder of Series A Preferred Shares.<br>|
| ***"Share Delivery Date"*** <br>| has the meaning given in Paragraph 4.3.<br>|
| ***"Standard Settlement Period"***  | means the standard settlement period, expressed in a number of Trading Days, on the Company's primary Trading Market with respect to the Ordinary Shares as in effect on the date of delivery of the Notice of Conversion.<br>|
| ***"Stated Value"*** | means in respect of the Series A Preferred Shares, $1,000. |

---

---

| | |
|:---|:---|
| ***"Successor Entity"*** <br>| has the meaning given in Paragraph 5.4. |
| ***"Trading Day"*** | means a day on which the principal Trading Market is open for business.<br>|
| ***"Trading Market"***  | means any of the following markets or exchanges on which the Ordinary Shares are listed or quoted for trading on the date in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE MKT or the New York Stock Exchange (or any successors to any of the foregoing).<br>|
| ***"Transfer Agent"*** | means Continental Stock Transfer & Trust Company, the current transfer agent of the Company, with a mailing address of 1 State Street, 30th Floor, New York, NY 10004-1561 and an email address of cstmail@continentalstock.com and any successor transfer agent of the Company.<br>|
| ***"VWAP"*** | means the volume-weighted average price of the Ordinary Shares for the five (5) Trading Days immediately preceding the date of Conversion of the Series A Preferred Shares, as reported by the principal Trading Market. |

---

**2.** **Designation of Series A Preferred Shares** 

2.1 Out
 of the 50,000,000 Preferred Shares authorised under this Amended and Restated Memorandum of Association, 6,000 Preferred Shares are
 hereby designated as Series A Preferred Shares. Each Series A Preferred Share shall have the rights, preferences, privileges and
 restrictions set out in this Schedule.

**3.** **Rights of Series A Preferred shares** 

3.1 Except
 as otherwise provided in these Articles or as otherwise required by law, the Series A Preferred Shares shall have no voting rights.
 However, as long as any shares of Series A Preferred Shares are outstanding, the Company shall not, whether by amendment, merger,
 or any other means, without the affirmative consent of the Series A Preferred Shareholders of a majority of the then outstanding
 Preferred Shares:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) alter
 or change adversely the powers, preferences or rights attached to the Series A Preferred Shares;

(b) amend
 its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the Series A Preferred
 Shareholders;

(c) increase
 the number of Series A Preferred Shares which the Company may issue;

(d) enter
 into or consummate any Fundamental Transaction; or

(e) enter
 into any agreement with respect to any of the foregoing.

3.2 For
 the purposes of Paragraph 3.1, the affirmative consent of the Series A Preferred Shareholders shall be given by either:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) a
 written resolution of the Series A Preferred Shareholders, signed by a majority of the Series A Preferred Shareholders; or

(g) at
 a duly convened meeting of Members, by a majority of Series A Preferred Shareholders who are present.

3.3 Except
 for Dividends or distributions for which adjustments are to be made pursuant to Paragraph 5.1 of this Schedule, Series A Preferred
 Shareholders shall be entitled to receive, and the Company shall pay, dividends on shares of Series A Preferred Shares equal (on
 an as-if-converted-to-Ordinary-Share basis, without regard to conversion limitations herein) to and in the same form as dividends
 actually paid on shares of the Ordinary Shares when, as and if such dividends are paid the Ordinary Shares. No other dividends shall
 be paid on the Series A Preferred Shares. The Company shall not pay any Dividends on the Ordinary Shares unless the Company simultaneously
 complies with this provision.

3.4 Upon
 any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary ( ***Liquidation***), the Series
 A Preferred Shareholders shall be entitled to receive out of the assets, whether capital or surplus, of the Company the same amount
 that a holder of Ordinary Shares would receive if the Series A Preferred Shares were fully converted (disregarding for such purposes
 any conversion limitations hereunder) to Ordinary Shares which amounts shall be paid pari passu with all holders of Ordinary Shares.
 The Company shall mail written notice of any such Liquidation, not less than 45 days prior to the payment date stated therein, to
 each holder of Preferred shares.

**4.** **Conversion of Series A Preferred Shares** 

4.1 Each
 Series A Preferred Share shall be convertible, at any time and from time to time, from and after the Original Issue Date at the option
 of the Series A Preferred Shareholder thereof, into that number of Ordinary Shares (subject to the limitations set forth in Paragraph
 4.11) determined by dividing the Stated Value of such Series A Preferred Share by the Conversion Price. Series A Preferred Shareholders
 shall effect conversions by providing the Company with the form of conversion notice agreed between the Company and Series A Preferred
 Shareholder (a  ***Notice of Conversion***). Each Notice of Conversion shall specify the number of Series A Preferred Shares
 to be converted, the number of shares of Series A Preferred Shares owned prior to the conversion at issue, the number of shares of
 Series A Preferred Shares owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which
 date may not be prior to the date the applicable Series A Preferred Shareholder delivers by facsimile such Notice of Conversion to
 the Company (such date, the  ***Conversion Date***). If no Conversion Date is specified in a Notice of Conversion, the Conversion
 Date shall be the date that such Notice of Conversion to the Company is deemed delivered hereunder. A wet-ink original Notice of
 Conversion shall not be required, nor shall any medallion guarantee (or other type of guarantee or notarisation) of any Notice of
 Conversion form be required. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest
 or mathematical error. To effect conversions of Series A Preferred Shares, a Series A Preferred Shareholder shall not be required
 to surrender the certificate(s) representing the Series A Preferred Shares to the Company unless all of the Series A Preferred Shares
 represented thereby are so converted, in which case such Series A Preferred Shareholder shall deliver the certificate representing
 such Series A Preferred Shares promptly following the Conversion Date at issue. Series A Preferred shares converted into Ordinary
 Shares or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued.

4.2 The
 conversion price for the Series A Preferred Shares shall be equal to 85% of the VWAP of the Ordinary Shares (which is a 15% discount
 to the VWAP) immediately preceding the Conversion Date, subject to adjustment herein (the  ***Conversion Price***).

4.3 Not
 later than the earlier of two (2) Trading Days and the number of Trading Days comprising the Standard Settlement Period each Conversion
 Date (the  ***Share Delivery Date***), the Company shall deliver, or cause to be delivered, to the converting Series A Preferred
 Shareholder:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the
 number of Conversion Shares being acquired upon the conversion of the Series A Preferred Shares, which Conversion Shares shall be
 free of restrictive legends and trading restrictions; and

(b) a
 bank cheque in the amount of accrued and unpaid dividends, if any.

4.4 The
 Company shall use its best efforts to deliver the Conversion Shares required to be delivered by the Company under this Paragraph
 4 electronically through the Depository Trust Company ( ***DTC***), or another established clearing corporation performing
 similar functions. Notwithstanding the foregoing, with respect to any Notice(s) of Conversion delivered by 12:00 pm on the Closing
 Date, the Company shall deliver the Conversion Shares subject to such notice(s) by 4:00 pm on the Closing Date.

4.5 If,
 in the case of any Notice of Conversion, such Conversion Shares are not delivered to or as directed by the applicable Series A Preferred
 Shareholder by the Share Delivery Date, the Series A Preferred Shareholder shall be entitled to elect by written notice to the Company
 at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Company shall promptly
 return to the Series A Preferred Shareholder any original Series A Preferred Share certificate(s) delivered to the Company and the
 Series A Preferred Shareholder shall promptly return to the Company, the Conversion Shares issued to such Series A Preferred Shareholder
 pursuant to the rescinded Notice of Conversion.

4.6 The
 Company's obligation to issue and deliver the Conversion Shares upon conversion of Series A Preferred Shares in accordance
 with the terms of these Articles are absolute and unconditional, irrespective of any action or inaction by a Series A Preferred Shareholder
 to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person
 or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach
 by such Series A Preferred Shareholder or any other Person of any obligation to the Company or any violation or alleged violation
 of law by such Series A Preferred Shareholder or any other person, and irrespective of any other circumstance which might otherwise
 limit such obligation of the Company to such Series A Preferred Shareholder in connection with the issuance of such Conversion Shares;
 provided, however, that such delivery shall not operate as a waiver by the Company of any such action that the Company may have against
 such Series A Preferred Shareholder. If the Company fails to deliver to a Series A Preferred Shareholder such Conversion Shares pursuant
 to Paragraph 4.3 by the Share Delivery Date applicable to such conversion, then, subject to the Company's right to cure within
 two (2) Trading Days following written notice from such Series A Preferred Shareholder, the Company shall pay to such Series A Preferred
 Shareholder, in cash, as liquidated damages and not as a penalty, for each $10.00 of Stated Value of Series A Preferred Shares being
 converted, $0.50 per Trading Day for each Trading Day after the Share Delivery Date until such Conversion Shares are delivered or
 Series A Preferred Shareholder rescinds such conversion. Nothing herein shall limit a Series A Preferred Shareholder's right
 to pursue actual damages for the Company's failure to deliver Conversion Shares within the period specified herein, and such
 Series A Preferred Shareholder shall have the right to pursue all remedies available to it hereunder, at law or in equity including,
 without limitation, specific performance and/or injunctive relief.

4.7 In
 addition to any other rights available to the Series A Preferred Shareholder, if the Company fails for any reason to deliver to a
 Series A Preferred Shareholder the applicable Conversion Shares by the Share Delivery Date pursuant to Paragraph 4.1, and if after
 such Share Delivery Date such Series A Preferred Shareholder is required by its brokerage firm to purchase (in an open market transaction
 or otherwise), or the Series A Preferred Shareholder's brokerage firm otherwise purchases, Ordinary Shares to deliver in satisfaction
 of a sale by such Series A Preferred Shareholder of the Conversion Shares which such Series A Preferred Shareholder was entitled
 to receive upon the conversion relating to such Share Delivery Date, then the Company shall have two (2) Trading Days following written
 notice from the Series A Preferred Shareholder to cure such failure. If the Company does not cure within such period, it shall (A)
 pay in cash to such Series A Preferred Shareholder (in addition to any other remedies available to or elected by such Series A Preferred
 Shareholder) the amount, if any, by which (x) such Series A Preferred Shareholder's total purchase price (including any brokerage
 commissions) for the Ordinary Shares so purchased exceeds (y) the product of (1) the aggregate number of Ordinary Shares that such
 Series A Preferred Shareholder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which
 the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of
 such Series A Preferred Shareholder, either reissue (if surrendered) Series A Preferred Shares equal to the number of Series A Preferred
 Shares submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Series A Preferred
 Shareholder the number of shares of Ordinary Shares that would have been issued if the Company had timely complied with its delivery
 requirements under Paragraph 4.3.

4.8 The
 Company shall at all times reserve and keep available out of its authorised and unissued Ordinary Shares (for the sole purpose of
 issuance upon conversion of the Series A Preferred Shares in accordance with these Articles), free from pre-emption rights or any
 other actual contingent purchase rights of Persons other than the Series A Preferred Shareholder (and the other holders of the Series
 A Preferred Shares), not less than such aggregate number of Ordinary Shares as shall be issuable upon the conversion of the then
 outstanding shares of Series A Preferred Shares.

4.9 No
 fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Series A Preferred Shares. As
 to any fraction of a share which the Series A Preferred Shareholder would otherwise be entitled to purchase upon such conversion,
 the Company shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
 multiplied by the Conversion Price or round up to the next whole share.

4.10 The
 issuance of Conversion Shares on conversion of the Series A Preferred Shares shall be made without charge to any Series A Preferred
 Shareholder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion
 Shares, provided that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in
 the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Series A Preferred Shareholders
 of such shares of Series A Preferred Shares and the Company shall not be required to issue or deliver such Conversion Shares unless
 or until the Person or Persons requesting the issuance thereof shall have paid to the Company the amount of such tax or shall have
 established to the satisfaction of the Company that such tax has been paid. The Company shall pay all Transfer Agent fees required
 for same-day processing of any Notice of Conversion and all fees to the DTC (or another established clearing corporation performing
 similar functions) required for same-day electronic delivery of the Conversion Shares.

4.11 Notwithstanding
 anything to the contrary herein, the Company shall not effect any conversion of the Series A Preferred Shares, and a Series A Preferred
 Shareholder shall not have the right to convert any portion of the Series A Preferred Shares, to the extent that, after giving effect
 to the conversion set forth on the applicable Notice of Conversion, such Series A Preferred Shareholder (together with such Series
 A Preferred Shareholder's Affiliates, and any Persons acting as a group together with such Series A Preferred Shareholder or
 any of such Series A Preferred Shareholder's Affiliates (such Persons,  ***Attribution Parties***)) would beneficially
 own in excess of the Beneficial Ownership Limitation. For purposes of the foregoing sentence, the number of Ordinary Shares beneficially
 owned by such Series A Preferred Shareholder and its Affiliates and Attribution Parties shall include the number of shares of Ordinary
 Shares issuable upon conversion of the Series A Preferred Shares with respect to which such determination is being made, but shall
 exclude the number of Ordinary Shares which are issuable upon (i) conversion of the remaining, unconverted Stated Value of Series
 A Preferred Shares beneficially owned by such Series A Preferred Shareholder or any of its Affiliates or Attribution Parties and
 (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company subject to a limitation
 on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Series A Preferred Shares)
 beneficially owned by such Series A Preferred Shareholder or any of its Affiliates or Attribution Parties. Except as set forth in
 the preceding sentence, for purposes of this Paragraph 4.11, beneficial ownership shall be calculated in accordance with Section
 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this
 Paragraph 4.11 applies, the determination of whether the Series A Preferred Shares are convertible (in relation to other securities
 owned by such Series A Preferred Shareholder together with any Affiliates and Attribution Parties) and of how many shares of Series
 A Preferred Shares are convertible shall be in the sole discretion of such Series A Preferred Shareholder, and the submission of
 a Notice of Conversion shall be deemed to be such Series A Preferred Shareholder's determination of whether the shares of Series
 A Preferred Shares may be converted (in relation to other securities owned by such Series A Preferred Shareholder together with any
 Affiliates and Attribution Parties) and how many Series A Preferred Shares are convertible, in each case subject to the Beneficial
 Ownership Limitation. To ensure compliance with this restriction, each Series A Preferred Shareholder will be deemed to represent
 to the Company each time it delivers a Notice of Conversion that such conversion will not violate the restrictions set forth in this
 Paragraph 4.11 and the Company shall have no obligation to verify or confirm the accuracy of such representation. In addition, a
 determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act
 and the rules and regulations promulgated thereunder. For purposes of this Paragraph 4.11, in determining the number of outstanding
 Ordinary Shares, a Series A Preferred Shareholder may rely solely on the number of outstanding Ordinary Shares as stated in a written
 notice by the Company or the Transfer Agent setting forth the number of Ordinary Shares outstanding. Upon the written or oral request
 (which may be via email) of a Series A Preferred Shareholder, the Company shall within two Trading Days confirm orally and in writing
 to such Series A Preferred Shareholder the number of Ordinary Shares then outstanding. In any case, the number of Ordinary Shares
 shall be determined after giving effect to the conversion or exercise of securities of the Company, including the Series A Preferred
 Shares, by such Series A Preferred Shareholder or its Affiliates or Attribution Parties since the date as of which such number of
 Ordinary Shares was reported. The provisions of this Paragraph 4.11 shall be construed and implemented in a manner otherwise than
 in strict conformity with the terms of this Paragraph 4.11 to correct this paragraph (or any portion hereof) which may be defective
 or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or
 desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder
 of Series A Preferred Shares.

**5.** **Certain Adjustments to Series A Preferred Shares** 

5.1 If
 the Company, at any time while the Series A Preferred Shares are outstanding: (i) pays a dividend or otherwise makes a distribution
 or distributions payable in respect of Ordinary Shares or any other Ordinary Share Equivalents (which, for avoidance of doubt, shall
 not include any Ordinary Shares issued by the Company upon conversion of, or payment of a dividend on, the Series A Preferred Shares),
 (ii) subdivides outstanding Ordinary Shares into a larger number of shares, (iii) combines (including by way of a reverse share split,
 or share consolidation) outstanding Ordinary Shares into a smaller number of shares, or (iv) issues, in the event of a reclassification
 of Ordinary Shares, any shares of the Company, then the Conversion Price shall be multiplied by a fraction of which the numerator
 shall be the number of Ordinary Shares (excluding any treasury shares of the Company) outstanding immediately before such event,
 and of which the denominator shall be the number of Ordinary Shares outstanding immediately after such event. Any adjustment made
 pursuant to this Paragraph 5.1 shall become effective immediately after the record date for the determination of Members entitled
 to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
 combination or re-classification.

5.2 In
 addition to any adjustments pursuant to Paragraph 5.1, if at any time the Company grants, issues or sells any Ordinary Share Equivalents
 or rights to purchase stock, warrants, securities or other property pro rata to the record holders of Ordinary Shares (the  ***Purchase Rights***), then the Series A Preferred Shareholder will be entitled to acquire, upon the terms applicable to such Purchase
 Rights, the aggregate Purchase Rights which the Series A Preferred Shareholder could have acquired if the Series A Preferred Shareholder
 had held the number of Ordinary Shares acquirable upon complete conversion of such Series A Preferred Shareholder's Series
 A Preferred Shares (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
 Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if
 no such record is taken, the date as of which the record holders of Ordinary Shares are to be determined for the grant, issue or
 sale of such Purchase Rights (provided, however, to the extent that the Series A Preferred Shareholder's right to participate
 in any such Purchase Right would result in the Series A Preferred Shareholder exceeding the Beneficial Ownership Limitation, then
 the Series A Preferred Shareholder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
 of such Ordinary Shares as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in
 abeyance for the Series A Preferred Shareholder until such time, if ever, as its right thereto would not result in the Series A Preferred
 Shareholder exceeding the Beneficial Ownership Limitation).

5.3 During
 such time as the Series A Preferred Shares are outstanding, if the Company declares or makes any dividend or other distribution of
 its assets (or rights to acquire its assets) to holders of Ordinary Shares, by way of return of capital or otherwise (including,
 without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
 corporate rearrangement, scheme of arrangement or other similar transaction) (a  ***Distribution***), at any time after the
 issuance of Series A Preferred Shares, then, in each such case, the Series A Preferred Shareholder shall be entitled to participate
 in such Distribution to the same extent that the Series A Preferred Shareholder would have participated therein if the Series A Preferred
 Shareholder had held the number of Ordinary Shares acquirable upon complete conversion of the Series A Preferred Shares (without
 regard to any limitations on conversion hereof, including without limitation, the Beneficial Ownership Limitation) immediately before
 the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
 of Ordinary Shares are to be determined for the participation in such Distribution (provided, however, to the extent that the Series
 A Preferred Shareholder's right to participate in any such Distribution would result in the Series A Preferred Shareholder
 exceeding the Beneficial Ownership Limitation, then the Series A Preferred Shareholder shall not be entitled to participate in such
 Distribution to such extent (or in the beneficial ownership of any shares of Ordinary Shares as a result of such Distribution to
 such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Series A Preferred Shareholder
 until such time, if ever, as its right thereto would not result in the Series A Preferred Shareholder exceeding the Beneficial Ownership
 Limitation).

5.4 If,
 at any time while any Series A Preferred Shares are outstanding:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the
 Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into
 another Person;

(b) the
 Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
 substantially all of its assets in one or a series of related transactions;

(c) any,
 direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
 to which holders of Ordinary Shares are permitted to sell, tender or exchange their shares for other securities, cash or property
 and has been accepted by the holders of 50% or more of the outstanding Ordinary Shares;

(d) the
 Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganisation or recapitalisation
 of the Ordinary Shares or any compulsory share exchange pursuant to which the Ordinary Shares are effectively converted into or exchanged
 for other securities, cash or property; or

(e) the
 Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
 combination (including, without limitation, a reorganisation, recapitalisation, spin-off or scheme of arrangement) with another Person
 whereby such other Person acquires more than 50% of the outstanding Ordinary Shares (not including any Ordinary Shares held by the
 other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock
 or share purchase agreement or other business combination) (each a  ***Fundamental Transaction***),

then, upon any subsequent conversion of the Series A Preferred Shares by the Series A Preferred Shareholder thereof, the Series A Preferred Shareholder shall receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Paragraph 4.11 on the conversion of the Series A Preferred Shares), the number of ordinary shares (as applicable) of the successor or acquiring corporation or the number of Ordinary Shares (as applicable), if it is the surviving corporation, and all additional securities (equity or debt), cash, property or other consideration (all such additional consideration, the ***Alternate Consideration***), receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary Shares for which such Series A Preferred Shareholder's Series A Preferred Shares are convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Paragraph 4.11 on the conversion of the Series A Preferred Shares). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one Ordinary Share in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Ordinary Shares are entitled to elect the proportion of securities, cash, property or other consideration to be received by holders of Ordinary Shares in a Fundamental Transaction, then each Series A Preferred Shareholder of Series A Preferred Shares shall be given the same choice as to the proportion of securities, cash, property or other consideration such Series A Preferred Shareholder is entitled to receive upon any conversion of such Series A Preferred Shareholder's shares of Series A Preferred Shares following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Company or surviving entity in such Fundamental Transaction shall file a new certificate of designations in respect of a new series of preferred shares of the successor or acquiring corporation, or the Company, if it is the surviving corporation, setting forth the same rights, preferences, privileges and other terms contained in this certificate of designations in respect of the Series A Preferred Shares, including, without limitation, the provisions contained in this Paragraph 5.4 and evidencing, among other things, the Series A Preferred Shareholders' right to convert such new preferred shares into Alternate Consideration. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the ***Successor Entity***) to assume in writing all of the obligations of the Company in accordance with the provisions of this Paragraph 5.4 pursuant to written agreements in form and substance reasonably satisfactory to the Series A Preferred Shareholder and approved by the Series A Preferred Shareholder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of a Series A Preferred Shareholder of Series A Preferred Shares, deliver to such Series A Preferred Shareholder in exchange for such Series A Preferred Shareholder's Series A Preferred Shares a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Series A Preferred Shares which are convertible for a corresponding number of shares of capital shares of such Successor Entity (or its parent entity) equivalent to the Ordinary Shares acquirable and receivable upon conversion of the Series A Preferred Shares (without regard to any limitations on the conversion of the Series A Preferred Shares) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital shares (but taking into account the relative value of the Ordinary Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Series A Preferred Shares immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Series A Preferred Shareholder(s) thereof. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for, and may exercise every right and power of the Company and shall assume all of the obligations of the Company with the same effect as if such Successor Entity had been named as the Company herein. For the avoidance of doubt, if, at any time while any shares of Series A Preferred Shares are outstanding, a Fundamental Transaction occurs, pursuant to the terms of this Paragraph 5.4, a Series A Preferred Shareholder of Series A Preferred Shares shall not be entitled to receive any consideration in such Fundamental Transaction in respect of such Series A Preferred Shareholder's shares of Series A Preferred Shares, except as provided for in these Articles (or any certificate of designations in respect of a new series of preferred shares issued to the Series A Preferred Shareholders of Series A Preferred Shares as contemplated hereby).

5.5 All
 calculations under this Paragraph 5 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
 purposes of this Paragraph 5, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum
 of the number of Ordinary Shares (excluding any treasury shares of the Company) issued and outstanding.

5.6 Whenever
 the Conversion Price is adjusted pursuant to any provision of this Paragraph 5, the Company shall promptly deliver to each Series
 A Preferred Shareholder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of
 the facts requiring such adjustment.

5.7 If:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the
 Company shall declare a dividend (or any other distribution in whatever form) on the Ordinary Shares;

(b) the
 Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary Shares;

(c) the
 Company shall authorise the granting to all holders of the Ordinary Shares, rights or warrants to subscribe for or purchase any shares
 of any class or of any rights;

(d) the
 approval of any Members of the Company shall be required in connection with any reclassification of Ordinary Shares, any consolidation
 or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any
 compulsory share exchange whereby the Ordinary Shares are converted into other securities, cash or property; or

(e) the
 Company shall authorise the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company,

then, in each case, the Company shall cause to be filed at each office or agency maintained for the purpose of conversion of the Series A Preferred Shares, and shall cause to be delivered to each Series A Preferred Shareholder at its last address as it shall appear upon the register of members of the Company, at least fifteen (15) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the
 date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record
 is not to be taken, the date as of which the holders of the Ordinary Shares to be entitled to such dividend, distributions, redemption,
 rights or warrants are to be determined; or

(ii) the
 date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close,
 and the date as of which it is expected that holders of the Ordinary Shares shall be entitled to exchange their Ordinary Shares for
 securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange,
 provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of
 the corporate action required to be specified in such notice.

5.8 To
 the extent that any notice provided under Paragraph 5.7 constitutes, or contains, material, non-public information regarding the
 Company, the Company shall simultaneously file such notice with the Commission pursuant to a current report on Form 6-K. The Series
 A Preferred Shareholder shall remain entitled to convert the Conversion Amount of the Series A Preferred Shares (or any part hereof)
 during the 15-day period commencing on the date of such notice through the effective date of the event triggering such notice except
 as may otherwise be expressly set forth herein.

**6.** **Miscellaneous** 

6.1 Any
 and all notices or other communications or deliveries to be provided by the Series A Preferred Shareholders hereunder including,
 without limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile, email address or sent by
 a nationally recognized overnight courier service, addressed to the Company at:

**Address:**

Black Titan Corporation

Level 8, Unit 802, The Bousteador

10 Jalan PJU 7/6

Mutiara Damansara

47800 Petaling Jaya

Selangor Darul Ehsan

Malaysia Attention: Brynner Chiam

**Email address:** <u>bchiam@titanpharm.com</u>

or such other facsimile number or address as the Company may specify for such purposes by notice to the Series A Preferred Shareholders delivered in accordance with this Paragraph 6.1. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile, by email attachment or sent by a nationally recognized overnight courier service addressed to each Series A Preferred Shareholder at the facsimile number, email address or address of such Series A Preferred Shareholder appearing on the books of the Company, or if no such facsimile number, email address or address appears on the books of the Company, at the principal place of business of such Series A Preferred Shareholder. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the Person to whom such notice is required to be given. Notwithstanding any other provision of this Schedule, where this Schedule provides for notice of any event to a Series A Preferred Shareholder, if the Series A Preferred Shares are held in global form by DTC (or any successor depositary), such notice may be delivered via DTC (or such successor depositary) pursuant to the procedures of DTC (or such successor depositary).

6.2 Except
 as expressly provided herein, no provision of this Schedule shall alter or impair the obligation of the Company, which is absolute
 and unconditional, to pay liquidated damages and accrued dividends, as applicable, on the shares of Series A Preferred Shares at
 the time, place, and rate, and in the coin or currency, herein prescribed.

6.3 If
 a Series A Preferred Shareholder's share certificate shall be mutilated, lost, stolen or destroyed, the Company shall execute
 and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution
 for a lost, stolen or destroyed certificate, a new certificate for the Series A Preferred Shares so mutilated, lost, stolen or destroyed,
 but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably
 satisfactory to the Company.

6.4 If
 any shares of Series A Preferred Shares shall be converted, redeemed or reacquired by the Company, such shares shall resume the status
 of authorised but unissued shares of preferred shares and shall no longer be designated as Series A Preferred Shares.

## Exhibit 5.1

**EXHIBIT 5.1**

Harney Westwood & Riegels (Cayman) LLP

3rd Floor, Harbour Place

103 South Church Street, PO Box 11088

Grand Cayman KY1-1008, Cayman Islands

Tel: +1 345 949 8599

Fax: +1 345 949 4451

**DATE: 25 September 2025**

christopher.hall@harneys.com

george.weston@harney.com

066309.0001-CH-GYW

**Black Titan Corporation**

FFP (Corporate Services) Limited

2nd Floor Harbour Centre

159 Mary Street

George Town

Grand Cayman

KY1-9006

Cayman Islands

Dear Black Titan Corporation

**Black Titan Corporation (*Company*)**

We are lawyers qualified to practise in the Cayman Islands and have acted as Cayman Islands legal advisers to the Company in connection with the Company's registration statement on Form F-4 filed with the Securities and Exchange Commission (***Commission***) and declared effective 21 July 2025 (***Registration Statement***), relating to the registration of 7,210,800 ordinary shares of $0.001 par value each in the Company (***Ordinary Shares***) under the United States Securities Act of 1933, as amended (***Securities Act***) and pursuant to the terms of the Registration Statement.

Pursuant to their respective terms, upon consummation of the Business Combination (as defined in the Registration Statement), TTNP warrants (as referred to in the Registration Statement) expiring 1 December 2025, 20 July 2026, and 4 August 2027 (***Warrants***), a holder of a Warrant shall have the right to receive one Ordinary Share, for each share of TTNP Common Stock (as defined in the Registration Statement) that would have been issuable upon exercise of the Warrant immediately prior to the TTNP Merger (as defined in the Registration Statement).

We are furnishing this opinion as Exhibit 5.1 to the Registration Statement.

In this opinion ***Companies Act*** means the Companies Act, as amended, of the Cayman Islands.

For the purposes of giving this opinion, we have examined the Documents (as defined in Schedule 1) which are all the documents which we consider necessary and appropriate for the matters set out in this legal opinion. We have not examined any other documents, official or corporate records or external or internal registers and have not undertaken or been instructed to undertake any further enquiry or due diligence in relation to the transaction which is the subject of this opinion.

In giving this opinion, we have relied upon the assumptions set out in Schedule 2 which we have not independently verified.

Based solely upon the foregoing examinations and assumptions and upon such searches as we have conducted and having regard to legal considerations which we deem relevant, and subject to the qualifications set out in Schedule 3, we are of the opinion that under the laws of the Cayman Islands:

---

| | |
|:---|:---|
| 1 | **Ordinary Shares.** The Ordinary Shares to be issued by the Company as contemplated by the Registration Statement have been duly authorised and, when allotted, issued and fully paid for in accordance with the Resolutions (as defined in Schedule 1), and when the name of the shareholder is entered in the register of members of the Company (*Register of Members*), the Ordinary Shares will be validly issued, allotted and fully paid, non-assessable and there will be no further obligation on the holder of any of the Ordinary Shares to make any further payment to the Company in respect of such Ordinary Shares. |
| **2** | **Warrant Shares.** The Ordinary Shares to be issued by the Company on the exercise of the Warrants (and as contemplated by the Warrants), have been duly authorised and, when allotted, issued, and fully paid for in accordance with the Resolutions and the terms of the Warrants, and when the name of the shareholder is entered in the Register of Members, will be validly issued, allotted, and fully paid, non-assessable and there will be no further obligation on the holder to make any further payment to the Company in respect of such Warrants. |
| **3** | **Cayman Islands Law.** The statements under the caption "Taxation" in the proxy statement/prospectus forming part of the Registration Statement, to the extent that they constitute statements of Cayman Islands law, are accurate in all material respects as at the date of this opinion and such statements constitute our opinion. |

---

This opinion is confined to the matters expressly opined on herein and given on the basis of the laws of the Cayman Islands as they are in force and applied by the Cayman Islands courts at the date of this opinion. We have made no investigation of, and express no opinion on, the laws of any other jurisdiction. Except as specifically stated herein, we express no opinion as to matters of fact.

In connection with the above opinion, we hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to our name elsewhere in the Registration Statement. In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act, as amended, or the Rules and Regulations of the Commission thereunder.

This opinion is rendered for your benefit in connection with the transactions contemplated by the Registration Statement.

This opinion is limited to the matters referred to herein and shall not be construed as extending to any other matter or document not referred to herein.

This opinion shall be construed in accordance with the laws of the Cayman Islands.

---

| |
|:---|
| Yours faithfully |
| ![](ex5-1_001.jpg) |
| **Harney Westwood & Riegels (Cayman) LLP** |

---

**SCHEDULE 1**

List of Documents and Records Examined

---

| | |
|:---|:---|
| 1 | The Certificate of Incorporation of the Company dated 11 July 2024 and the Certificate of Incorporation on Change of Name dated 12 March 2025. |
| 2 | The Fourth Amended and Restated Memorandum and Articles of Association of the Company dated 18 September 2025 (***Mem & Arts***). |
| 3 | A Certificate of Incumbency in respect of the Company, issued by FFP (Corporate Services) Limited on 16 September 2025, as Registered Office provider to the Company (***Certificate of Incumbency***). |
| 4 | A Certificate of Good Standing in respect of the Company issued by the Registrar of Companies dated 16 September 2025. |
| 5 | The Register of Writs and other Originating Process of the Grand Court of the Cayman Islands (***Court Register***) via the Court's Digital System from the incorporation date of the Company to 25 September 2025. |
| 6 | A copy of the unanimous written resolutions of the board of directors of the Company dated 18 September 2025 approving the Issue (the ***Resolutions***). |

---

Items 1 to 6 above are together referred to as the ***Corporate Documents***.

---

| | |
|:---|:---|
| 7.0 | A certificate dated 23 September 2025 provided by a director of the Company confirming certain matters to us which are relevant to our opinion (***Director's Certificate***). |
| 8.0 | The Registration Statement. |

---

1 to 8 above are collectively referred to in this opinion as the ***Documents***.

**Schedule 2**

Assumptions

---

| | |
|:---|:---|
| 1 | **Validity under Foreign Laws.** That: |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) all
 formalities required under any applicable laws (other than the laws of the Cayman Islands)
 have been complied with; and

(b) no
 other matters arising under any foreign law will affect the views expressed in this opinion.

---

| | |
|:---|:---|
| 2.0 | **Authenticity of Documents.** All original Documents are authentic, all signatures, initials and seals are genuine, all copies of Documents are true and correct copies and the Registration Statement conforms in every material respect to the latest drafts of the same produced to us and, where the Registration Statement has been provided to us in successive drafts marked-up to indicate changes to such documents, all such changes have been so indicated. |
| 3.0 | **Corporate Documents.** All matters required by law to be recorded in the Corporate Documents are so recorded, and all corporate minutes, resolutions, certificates, documents and records which we have reviewed are accurate and complete, and all facts expressed in or implied thereby are accurate and complete. |
| 4.0 | **Director's Certificate**. The contents of the Director's Certificate are true and accurate as at the date of this opinion and there is no information not contained in the Director's Certificate that will in any way affect this opinion. |

---

**Schedule 3**

Qualifications

---

| | |
|:---|:---|
| 1 | **Non-assessable.** The term ***non-assessable*** means, with respect to shares in the Company, that a shareholder shall not, solely by virtue of its status as a shareholder, be liable for additional assessments or calls on the shares by the Company or its creditors (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil). |
| 2 | **Foreign Statutes.** We express no opinion in relation to provisions making reference to foreign statutes in the Registration Statement. |
| 3 | **Good Standing.** The Company shall be deemed to be in good standing at any time if all fees (including annual filing fees) and penalties under the Companies Act have been paid and the Registrar of Companies in the Cayman Islands has no knowledge that the Company is in default under the Companies Act. |

---

**BLACK TITAN CORPORATION**

**incorporated in the Cayman Islands**

**Company No. 411832**

(***Company***)

**DIRECTOR's Certificate**

I, the undersigned, being a director of the Company, am aware that you are being asked to provide an opinion letter (***Opinion***) in relation to the Registration Statement.

Unless otherwise defined herein, capitalised terms used in this certificate have the respective meanings given to them in the Opinion.

I hereby certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. The
 Mem & Arts (as set out at Exhibit 2) remain in full force and effect.

&nbsp;&nbsp;&nbsp;&nbsp;2. The
 Resolutions (as set out at Exhibit 1) were duly passed in the manner prescribed in the Mem
 & Arts) and have not been amended, varied, or revoked in any respect.

&nbsp;&nbsp;&nbsp;&nbsp;3. The
 authorised share capital of the Company is US$1,050,000 divided into:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. 1,000,000,000
 ordinary shares $0.001 par value each in the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. 50,000,000
 preferred shares of $0.001 par value each in the capital of the Company ( ***Preferred Shares***).

&nbsp;&nbsp;&nbsp;&nbsp;4. No
 share will be issued for a price which is lower than its par value, and the Company will
 have sufficient authorised but unissued shares to issue the Ordinary Shares

5. The
 shareholders of the Company ( ***Shareholders***) have not restricted the powers of
 the Director in any way.

6. The
 Director at the date of the Resolutions and at the date of this certificate was and is Brynner
 Chiam.

7. Prior
 to, at the time of, and immediately following the approval of the transactions contemplated
 by the Resolutions, the Company was, or will be, able to pay its debts as they fell, or fall,
 due and has entered, or will enter, into the transactions contemplated by the Resolutions
 for proper value and not with an intention to defraud or wilfully defeat an obligation owed
 to any creditor or with a view to giving a creditor a preference.

8. Each
 Director considers the transactions contemplated by the Resolutions to be of commercial benefit
 to the Company and has acted in good faith in the best interests of the Company, and for
 a proper purpose of the Company, in relation to the transactions which are the subject of
 the Opinion.

9. The
 Directors or Shareholders have not taken any steps to have the Company struck off or placed
 in liquidation, nor have any steps been taken to wind up the Company. Nor has any receiver
 been appointed over any of the Company's property or assets.

## Exhibit 5.2

**Exhibit 5.2**

---

| | | |
|:---|:---|:---|
| ![](ex5-2_001.jpg) | **Loeb & Loeb LLP**<br>345 Park Avenue<br> New York, NY 10154 | <br>**Main** +1 212-407-4000<br> **Fax** +1 212-407-4990  |

---

September 25, 2025

Black Titan Corporation

Level 8, Unit 802, The Bousteador

10 Jalan PJU 7/6

Mutiara Damansara

47800 Petaling Jaya

Selangor Darul Ehsan

Malaysia

Dear Black Titan Corporation:

Reference is hereby made to that certain Merger and Contribution and Share Exchange Agreement, dated as of August 19, 2024 (the "<u>Merger Agreement</u>"), by and among Titan Pharmaceuticals, Inc., a Delaware Corporation (the "<u>TTNP</u>"), Black Titan Corporation, f/k/e BSKE Limited, a Cayman Islands exempted company limited by shares ("<u>PubCo</u>" or "<u>Black Titan</u>"), TTNP Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Black Titan ("<u>Merger Sub</u>"), and TalenTec Sdn. Bhd., f/k/e KE Sdn. Bhd., a Malaysia private limited company ("<u>TalenTec</u>"). Pursuant to the Merger Agreement, Merger Sub will merge with and into TTNP, with TTNP being the surviving corporation (the "<u>TTNP Merger</u>") and a direct wholly owned subsidiary of PubCo; each outstanding share of TTNP Common Stock, $0.001 par value per share ("<u>Common Stock</u>") will automatically be converted into one PubCo Ordinary Share, par value $0.001 per share ("<u>PubCo Ordinary Share</u>"); and each outstanding share of TTNP Series AA Convertible Preferred Stock will automatically be converted into 1.07296 PubCo Ordinary Shares (the transactions contemplated by the Merger Agreement, the "<u>Business Combination</u>"). In addition, immediately following effectiveness of the TTNP Merger, pursuant to a Share Exchange Agreement, dated July 25, 2025, among PubCo, TalenTec, and the TalenTec Shareholders (the "<u>Share Exchange Agreement</u>"), each TalenTec Shareholder will contribute and exchange each share of TalenTec owned by such TalenTec Shareholder for 8.524 PubCo Ordinary Shares. Up to a total of 7,210,800 PubCo Ordinary Shares (the "<u>BC Pubco Ordinary Shares</u>") will be issued pursuant to the Business Combination and the Share Exchange Agreement. Pursuant to their respective terms, upon consummation of the Business Combination, the holders of the TTNP warrants (as meant in the Registration Statement (defined below)) expiring December 1, 2025, July 20, 2026, and August 4, 2027 (collectively, the "<u>Warrants</u>"), shall have the right upon the exercise of each such Warrant to receive one PubCo Ordinary Share, for each share of Common Stock that would have been issuable upon exercise of the Warrant immediately prior to the TTNP Merger.

In connection with this opinion, we have examined copies of the Registration Statement on Form F-4, as amended (File No. 333-287709 (the "<u>Registration Statement</u>")), relating to the BC PubCo Ordinary Shares, filed by Black Titan with the Securities and Exchange Commission (the "<u>Commission</u>") under the Securities Act of 1933, as amended (the "<u>Securities Act</u>"), and declared effective by the Commission on July 21, 2025, and of the Prospectus, dated August 12, 2025, and supplements, dated August 14, 2025, August 15, 2025, August 22, 2025, and September 18, 2025, relating to the BC PubCo Ordinary Shares, in the form filed with the Commission under Rule 424 under the Securities Act. We have also examined such other documents and considered such legal matters as we have deemed necessary and relevant as the basis for the opinion set forth below. With respect to such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as reproduced or certified copies, and the authenticity of the originals of those latter documents. As to questions of fact material to this opinion, we have, to the extent deemed appropriate, relied upon certain representations of certain officers of the Company. Because the agreements governing the Warrants contain or incorporate provisions stating that they are to be governed by the laws of the State of New York, we are rendering this opinion as to New York law and have assumed the due authorization, execution and delivery of each such agreement by the Company in accordance with the laws of the Cayman Islands. We are admitted to practice in the State of New York, and we express no opinion as to any matters governed by any law other than the law of the State of New York. In particular, we do not purport to pass on any matter governed by the laws of the Cayman Islands.

Los Angeles New York Chicago Nashville Washington, DC San Francisco Tysons Beijing Hong Kong www.loeb.com

For the United States offices, a limited liability partnership including professional corporations. For Hong Kong office, a limited liability partnership.

---

| | |
|:---|:---|
| ![](ex5-2_002.jpg) | September 25, 2025<br>Page 2 |

---

Based upon the foregoing, upon consummation of the Business Combination in accordance with the Merger Agreement, the Warrants will constitute the valid and binding obligations of the Black Titan, enforceable against Black Titan in accordance with their respective terms.

The foregoing opinion is qualified to the extent that (a) enforceability may be limited by and be subject to general principles of equity, regardless whether such enforceability is considered in a proceeding in equity or at law (including, without limitation, concepts of notice and materiality), and by bankruptcy, insolvency, reorganization, moratorium and other similar laws affecting creditors' and debtors' rights generally (including, without limitation, any state or federal law in respect of fraudulent transfers); and (b) no opinion is expressed herein as to compliance with or the effect of federal or state securities or blue sky laws. In addition, we express no opinion as to: the right to collect any payment to the extent that such payment constitutes a penalty, premium, forfeiture or late payment charge; the enforceability of any governing law, consent to jurisdiction or forum selection provisions contained or incorporated into in the Warrants; waivers of right to trial by jury or defense; or any purported right of indemnification or exculpation with respect to illegal acts, intentional torts, violation of securities laws, negligence or willful misconduct.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference made to us under the caption "Legal Matters" in the proxy statement/prospectus constituting part of the Registration Statement. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Act, the rules and regulations promulgated thereunder.

---

| |
|:---|
| Very truly yours, |
| /s/ Loeb & Loeb LLP |
| Loeb & Loeb LLP |

---

## Exhibit 8.1

**Exhibit 8.1**

![](ex8-1_001.jpg)

September 22, 2025

Titan Pharmaceuticals Inc.

10 East 53rd Street, Suite 3001

New York, NY 10022-5064

Ladies and Gentlemen:

We have acted as United States tax counsel to Titan Pharmaceuticals Inc., a Delaware corporation ("TTNP" or "Parent") in connection with the Merger and Contribution and Share Exchange Agreement, dated August 19, 2024 (as may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement"), with Black Titan Corporation, formerly BSKE Limited, a Cayman Islands exempted company limited by shares ("PubCo"), TTNP Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of PubCo ("Merger Sub" and, together with PubCo, each, individually, an "Acquisition Entity" and, collectively, the "Acquisition Entities"), and TalenTec Sdn. Bhd., a Malaysia private limited company, formerly known as KE Sdn. Bhd. ("TalenTec" or "Company"). This opinion is being delivered in connection with the Registration Statement of PubCo on Form F-4 filed on June 2, 2025 with the Securities and Exchange Commission, as amended and supplemented through the date hereof (the "Registration Statement"). Capitalized terms used but not defined herein shall have the respective meanings set forth in the Registration Statement.

In providing our opinion, we have examined the Merger Agreement, the Registration Statement, and such other documents as we have deemed necessary or appropriate for purposes of this opinion. In our examination, we have assumed, without independent verification, (i) the authenticity of original documents, (ii) the accuracy of copies and the genuineness of signatures, (iii) that the execution and delivery by each party to a document and the performance by such party of its obligations thereunder have been authorized by all necessary measures and do not violate or result in a breach of or default under such party's certificate or instrument of formation and by-laws or the laws of such party's jurisdiction of organization, (iv) that each agreement represents the entire agreement between the parties with respect to the subject matter thereof, (v) that the parties to each agreement have complied, and will comply, with all of their respective covenants, agreements and undertakings contained therein, (vi) that the transactions provided for by each agreement were and will be carried out in accordance with their terms, (vii) that the Business Combination (as defined in the Merger Agreement) will be consummated as contemplated by the Merger Agreement, and (viii) that the parties have no plan or intention to waive or modify, and have not waived or modified, any of the material terms or conditions in the Merger Agreement. If any of the above described assumptions is untrue for any reason or if the transaction is consummated in a manner that is different from the manner described in the Merger Agreement or the Registration Statement, this opinion may be adversely affected. We have not undertaken any independent investigation of any factual matter set forth in any of the foregoing.

![](ex8-1_002.jpg)

September 22, 2025

The opinion set forth below is based on the Internal Revenue Code of 1986, as amended, administrative rulings, judicial decisions, Treasury regulations and other applicable authorities, all as in effect on the date hereof. The statutory provisions, regulations, and interpretations upon which our opinion is based are subject to change, and such changes could apply retroactively. Any change in law or the facts regarding the Business Combination or any of the transactions related thereto, or any inaccuracy in the facts or assumptions upon which we relied, could affect the continuing validity of the opinion set forth below. We assume no responsibility to inform you of any such changes or inaccuracies that may occur or come to our attention.

Based on such facts, assumptions and representations and subject to the limitations set forth herein and in the Registration Statement, it is our opinion that the discussion in the Registration Statement under the caption "Material U.S. Federal Income Tax Considerations of the Business Combination" insofar as such discussion purports to summarize the material U.S. federal income tax considerations of the TTNP Merger to holders of TTNP Common Stock and TTNP warrants is accurate in all material respects.

This opinion is being delivered prior to the consummation of the Business Combination and therefore is prospective and dependent on future events. This opinion is expressed as of the date hereof, and we are under no obligation to supplement or revise our opinion to reflect any legal developments, any factual matters arising subsequent to the date hereof, or the impact of any information, document, certificate, record, statement, representation, covenant, or assumption relied upon herein that becomes incorrect or untrue. We express our opinion herein only as to those matters specifically set forth above and no opinion should be inferred as to the tax consequences of the Business Combination under any state, local or foreign law, or with respect to other areas of United States federal taxation. We do not express any opinion herein concerning any law other than the federal income tax law of the United States.

This opinion is furnished to you solely in connection with the Business Combination, as described in the Merger Agreement and the Registration Statement, and this opinion is not to be relied upon for any other purpose without our prior written consent.

We hereby consent to the use of this opinion as an exhibit to the Registration Statement and to the use of our name therein. In giving this consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended (the "Securities Act"), or the rules and regulations of the Securities and Exchange Commission thereunder, nor do we admit that we are experts with respect to any part of the Registration Statement within the meaning of the term "experts" as used in the Securities Act or the rules and regulations of the Securities and Exchange Commission thereunder.

Very truly yours, <br>Olshan Frome Wolosky LLP

## Exhibit 10.7

**EXHIBIT 10.7**

**SHARE EXCHANGE AGREEMENT**

THIS SHARE EXCHANGE AGREEMENT (this "**Agreement**") is entered into as of 25 Jul 2025 by and among TalenTec Sdn. Bhd. (Company No. 199001001889 (193451-W), f/k/a KE Sdn. Bhd. ("**TalenTec**"), the shareholders of TalenTec who elect to become a party to this Agreement, as listed on <u>Schedule A</u> hereto (each a "**Shareholder**," and collectively, the "**Shareholders**"), and Black Titan Corporation (f/k/a BSKE Limited) ("**BSKE**").

TalenTec, Shareholders, and BSKE shall collectively be known as the "Parties" and "Party" shall mean any one or all of them.

**WHEREAS**, each Shareholder currently owns ordinary shares of TalenTec as listed on <u>Schedule A</u> hereto.

**WHEREAS**, BSKE is a newly formed entity, and was formed for the purpose of (a) participating in the transactions contemplated in a Merger and Contribution and Share Exchange Agreement entered into by and among BSKE, TTNP Merger Sub, Inc. and TalenTec ("**Merger Agreement**"), and (b) becoming the publicly traded holding company of TalenTec.

**WHEREAS**, the Shareholders own the numbers of ordinary shares of TalenTec set forth opposite their respective names on Schedule A, as at the date of this Agreement.

**WHEREAS**, each of the Shareholders desires to exchange all of his ordinary shares of TalenTec for ordinary shares of BSKE, and BSKE has agreed to offer the BSKE Shares (as defined below) in connection with such exchange to each of the Shareholders, upon the terms and conditions set forth in this Agreement and the Merger Agreement.

**WHEREAS**, following the Exchange (as defined below), TalenTec will become a wholly-owned subsidiary of BSKE.

**NOW, THEREFORE**, in consideration of the mutual promises, covenants and agreements herein, and intending to be legally bound hereby, the Parties agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;**1.** **Exchange of Shares.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **Exchange**.
 On the terms and subject to the conditions set forth in this Agreement and the Merger Agreement, at the Closing (as defined below),
 (i) Shareholders will contribute to BSKE, free and clear of all liens, pledges, encumbrances, changes, restrictions or known claims
 of any kind, nature or description, five hundred eighty thousand (580,000) ordinary shares comprising all the issued and paid up
 ordinary shares of TalenTec as at the date of this Agreement, in the individual amounts as set forth on <u>Schedule A</u>; (the "**TalenTec Shares** "); and (ii) in exchange for the contribution of the TalenTec Shares by the Shareholders, BSKE will issue to Shareholders
 such number of newly issued ordinary shares of BSKE as determined in accordance with the terms of the Merger Agreement (the "**BSKE Shares**") (such exchange referred to herein as the "**Exchange** "). Upon completion of the Exchange, all
 of the ordinary shares of TalenTec shall be held by BSKE.

(b) **Closing**.
 The closing of the Exchange (the "**Closing**") shall occur as of immediately prior to the Effective Time (as defined
 in the Merger Agreement).

&nbsp;&nbsp;&nbsp;&nbsp;**2.** **Representations and Warranties.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **Representations, Warranties, and Agreements of Shareholders**. Each of the Shareholders hereby represents and warrants to, BSKE and TalenTec, as
 follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Authorization; No Restrictions, Consents or Approvals and Capacity</u>. He has the legal right, full power, legal capacity and authority to enter
 into and perform his obligations under this Agreement and any other documents to be executed by him pursuant to or in connection
 with this Agreement, which, when executed, will constitute valid and binding obligations on him, in accordance with their respective
 terms; and no approvals or consents are necessary in connection with such execution and performance. All of the TalenTec Shares owned
 by him are, properly and validly allotted and issued, free of encumbrances and with the right to receive all dividends and distributions
 which may be declared, made and paid. He (A) is of sound mind, (B) is over the age of 18, (C) is not suffering from a mental disability,
 (D) is not bankrupt in any jurisdictions, and (E) has no knowledge of any bankruptcy petitions which have been presented against
 him or proposed to be presented against him, or events having occurred which would justify such proceedings.

(ii) <u>Transfer of TalenTec Shares</u>. The TalenTec Shares owned by him will, at the Closing, be validly transferred to BSKE, and such TalenTec
 Shares shall be fully paid, properly and validly allotted and issued, free of encumbrances and with the right to receive all dividends
 and distributions which may be declared, made and paid with the holder being entitled to all rights accorded to a holder of ordinary
 shares of TalenTec. He hereby waives all pre-emptive or similar rights, or any right of first refusal in respect of the TalenTec
 Shares.

(iii) <u>Beneficial Ownership</u>. The Shareholder has sole beneficial ownership, as meant in Section 13(d) of the United States Securities Exchange
 Act of 1934 and Securities and Exchange Commission rules thereunder, of his TalenTec Shares and will have sole beneficial ownership
 of the BSKE Shares to be received pursuant to the Exchange. The Shareholder does not, directly or indirectly, through any agreement,
 arrangement, understanding, relationship, or otherwise, share voting power or investment power, as meant in those rules, with any
 person, and there is no person, other than the Shareholder, who has or will have the right to receive or power to direct the receipt
 of dividends from or the proceeds of any disposition of his TalenTec Shares or BSKE Shares to be received pursuant to the Exchange.
 None of the Shareholder's TalenTec Shares is, or BSKE Shares to be received pursuant to the Exchange will be, held in any trust
 or custodial arrangement, by any nominee, or in or by any similar arrangement. There is no agreement, arrangement, or understanding,
 between the Shareholder and any person with respect to the management or policies of TalenTec or BSKE, and none is contemplated.

(iv) <u>No Other Agreements or Understandings</u>. Except solely as set forth herein, there is no contract, arrangement, understanding, or relationship
 (legal or otherwise) between the Shareholder and any person with respect to the Shareholder's TalenTec Shares or BSKE Shares
 to be received pursuant to the Exchange, in connection with any of the following: call options, put options, security-based swaps
 or any other derivative securities, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option
 arrangements, guarantees of profits, division of profits or loss, or the giving or withholding of proxies, and none of the Shareholder's
 TalenTec Shares or BSKE Shares to be received pursuant to the Exchange are or will be pledged or otherwise subject to a contingency
 the occurrence of which would give another person voting power or investment power over those securities.

(v) <u>Accuracy</u>.
 Each of the Shareholder's representations and warranties herein is, as of the date hereof, and, as of the Closing, will be,
 true, complete, and correct in all respects.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **Representations and Warranties of TalenTec.** TalenTec hereby represents and warrants to each Shareholder and BSKE, all of which representations
 and warranties are true, complete, and correct in all respects as of the date hereof and will be as of the Closing, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Organization and Qualification.</u> TalenTec is a corporation duly incorporated and validly existing under the laws of the jurisdiction of its
 incorporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Authorization; No Restrictions, Consents or Approvals.</u> TalenTec has full power and authority to enter into and perform its obligations under
 this Agreement. This Agreement has been duly executed by TalenTec and constitutes the legal, valid, binding and enforceable obligation
 of TalenTec, enforceable against TalenTec in accordance with its terms. The execution and delivery of this Agreement and the consummation
 by TalenTec of the transactions contemplated herein do not and will not on the Closing (A) conflict with or violate any of the terms
 of the constitution or charter or memorandum and articles of association or incorporation documents, as applicable, of TalenTec or
 any applicable law relating to TalenTec, (B) conflict with, or result in a breach of any of the terms of, or result in the acceleration
 of any indebtedness or obligations under, any material agreement, obligation or instrument by which TalenTec is bound or to which
 any property of TalenTec is subject, or constitute a default thereunder, other than those material agreements, obligations or instruments
 for which TalenTec has obtained consent for the transactions contemplated under this Agreement, (C) result in the creation or imposition
 of any lien on any of the assets of TalenTec, (D) constitute an event permitting termination of any material agreement or instrument
 to which TalenTec is a party or by which any property or asset of TalenTec is bound or affected, pursuant to the terms of such agreement
 or instrument, other than those material agreements or instruments for which TalenTec has obtained consent for the transactions contemplated
 under this Agreement, or (E) conflict with, or result in or constitute a default under or breach or violation of or grounds for termination
 of, any license, permit or other governmental authorization to which TalenTec is a party or by which TalenTec may be bound, or result
 in the violation by TalenTec of any laws to which TalenTec may be subject, which would materially adversely affect the transactions
 contemplated herein. No authorization, consent or approval of, notice to, or filing with, any public body or governmental authority
 or any other person is necessary or required in connection with the execution and delivery by TalenTec of this Agreement or the performance
 by TalenTec of its obligations hereunder.

(iii) <u>Capitalization</u>.
 The TalenTec Shares shall, at the Closing, constitute all of the issued and paid up share capital of TalenTec. There are no outstanding
 options, warrants, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or
 obligations convertible into or exchangeable for, or giving any person any right to subscribe for or acquire, the ordinary shares
 of TalenTec, or contracts, commitments, understandings or arrangements by which TalenTec is or may become bound to issue additional
 ordinary shares of TalenTec, or securities or rights convertible or exchangeable into ordinary shares of TalenTec. The TalenTec Shares
 are and shall be fully paid, properly and validly allotted and issued.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) **Representations and Warranties of BSKE.** BSKE hereby represents and warrants to each Shareholder and TalenTec, all of which representations and
 warranties are true, complete, and correct in all respects as of the date hereof and will be as of the Closing, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Organization and Qualification</u>. BSKE is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction
 of its incorporation.

(ii) <u>Authorization; No Restrictions, Consents or Approvals</u>. BSKE has full power and authority to enter into and perform its obligations under this
 Agreement. This Agreement has been duly executed by BSKE and constitutes the legal, valid, binding and enforceable obligation of
 BSKE, enforceable against BSKE in accordance with its terms. The execution and delivery of this Agreement and the consummation by
 BSKE of the transactions contemplated herein (including the issuance of the BSKE Shares in exchange for the TalenTec Shares) do not
 and will not on the Closing (A) conflict with or violate any of the terms of the constitution or charter or memorandum and articles
 of association or incorporation documents, as applicable, of BSKE or any applicable law relating to BSKE, (B) conflict with, or result
 in a breach of any of the terms of, or result in the acceleration of any indebtedness or obligations under, any material agreement,
 obligation or instrument by which BSKE is bound or to which any property of BSKE is subject, or constitute a default thereunder,
 other than those material agreements, obligations or instruments for which BSKE has obtained consent for the transactions contemplated
 under this Agreement, (C) result in the creation or imposition of any lien on any of the assets of BSKE, (D) constitute an event
 permitting termination of any material agreement or instrument to which BSKE is a party or by which any property or asset of BSKE
 is bound or affected, pursuant to the terms of such agreement or instrument, other than those material agreements or instruments
 for which BSKE has obtained consent for the transactions contemplated under this Agreement, or (E) conflict with, or result in or
 constitute a default under or breach or violation of or grounds for termination of, any license, permit or other governmental authorization
 to which BSKE is a party or by which BSKE may be bound, or result in the violation by BSKE of any laws to which BSKE may be subject,
 which would materially adversely affect the transactions contemplated herein. No authorization, consent or approval of, notice to,
 or filing with, any public body or governmental authority or any other person is necessary or required in connection with the execution
 and delivery by BSKE of this Agreement or the performance by BSKE of its obligations hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) <u>Issuance of Shares</u>. The BSKE Shares have been duly authorized and, upon issuance in accordance with the terms of this Agreement and the
 Merger Agreement, shall be validly issued and free from all taxes, liens and charges with respect to the issue thereof, and the BSKE
 Shares shall be fully paid and non-assessable with the holder being entitled to all rights accorded to a holder of ordinary shares
 of BSKE. The issuance of the BSKE Shares contemplated by this Agreement and the Merger Agreement will not, immediately or with the
 passage of time; (A) obligate BSKE to issue ordinary shares or other securities of BSKE to any other person, or (B) result in a right
 of any holder of ordinary shares or other securities of BSKE to adjust the exercise, conversion, exchange or reset price of such
 ordinary shares or other securities of BSKE.

(iv) <u>No Reliance</u>. BSKE has not relied on and is not relying on any representations, warranties or other assurances regarding TalenTec
 other than the representations and warranties expressly set forth in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;**3.** **Closing.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **Conditions to Shareholders' Obligations**. The obligations of each Shareholder under this Agreement (including, without limitation,
 the obligation to transfer the TalenTec Shares to BSKE in exchange for the BSKE Shares) shall be subject to satisfaction of the following
 conditions, unless waived by Shareholders: (i) BSKE shall have performed in all material respects all agreements, and satisfied in
 all material respects all conditions on its part to be performed or satisfied hereunder, at or prior to the Closing; (ii) all of
 the representations and warranties of TalenTec and BSKE herein shall have been true and correct in all respects when made, shall
 have continued to have been true and correct in all respects at all times subsequent thereto, and shall be true and correct in all
 material respects on and as of the Closing as though made on, as of, and with reference to such Closing; (iii) TalenTec and BSKE
 shall have executed and delivered to Shareholders all documents necessary to issue the BSKE Shares to the Shareholder, as contemplated
 by this Agreement (including those documents described in Section 3(c)); (iv) TalenTec and BSKE shall have obtained or made, as applicable,
 all consents, authorizations and approvals from, and all declarations, filings and registrations required to consummate the transactions
 contemplated by this Agreement, including all items required under the constitution or charter or memorandum and articles of incorporation
 association or incorporation documents, as applicable, of TalenTec and BSKE, respectively; and (v) all conditions set forth in Article
 IX of the Merger Agreement, except for the consummation of the Exchange, shall have been satisfied or waived (other than those conditions
 that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver thereof).

(b) **Conditions to BSKE Obligations**. The obligations of BSKE under this Agreement (including, without limitation, the obligation to issue the
 BSKE Shares in exchange for the TalenTec Shares) shall be subject to satisfaction of the following conditions, unless waived by BSKE:
 (i) Shareholders and TalenTec shall have performed in all respects all agreements, and satisfied in all respects all conditions on
 their part to be performed or satisfied hereunder, at or prior to the Closing; (ii) all of the representations and warranties of
 Shareholders and TalenTec herein shall have been true and correct in all material respects when made, shall have continued to have
 been true and correct in all material respects at all times subsequent thereto, and shall be true and correct in all material respects
 on and as of the Closing as though made on, as of, and with reference to such Closing; (iii) Shareholders and TalenTec shall have
 executed and delivered to BSKE all documents necessary to transfer the TalenTec Shares to BSKE, as contemplated by this Agreement
 (including those documents described in Section 3(c)); (iv) Shareholders and TalenTec shall have obtained or made, as applicable,
 all consents, authorizations and approvals from, and all declarations, filings and registrations required to consummate the transactions
 contemplated by this Agreement, including all items required under the constitution or charter or memorandum and articles of association
 or incorporation documents, as applicable, of TalenTec and BSKE, respectively; and (v) all conditions set forth in Article IX of
 the Merger Agreement, except any to be performed by BSKE, shall have been satisfied or waived (other than those conditions that by
 their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver thereof).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) **Closing Documents**. At the Closing:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) TalenTec
 and the Shareholders, as applicable, shall deliver to BSKE the following documents:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) valid
 and registrable instruments of transfer of the TalenTec Shares duly executed by each of the Shareholders in favour of BSKE accompanied
 by the corresponding original share certificates, if any, and TalenTec's latest audited financial statement;

(2) a
 certified true copy of the resolutions being passed at a board meeting of TalenTec approving the transfer of the TalenTec Shares
 from the Shareholders to BSKE on the terms and conditions as set out in this Agreement and the Merger Agreement;

(3) a
 certified true copy of the resolutions being passed at a board meeting of TalenTec approving the registration of the TalenTec Shares
 and the registration of BSKE in the share register book of TalenTec as the legal and beneficial holder of the TalenTec Shares following
 the Closing (subject to the instruments of transfers being dated and appropriately stamped);

(4) such
 waivers, consents and/or documents, if any, as BSKE may require to enable BSKE to be registered as the holder of the TalenTec Shares
 in the register of members of TalenTec upon receipt by the company secretary of TalenTec of the executed and stamped share transfer
 forms in respect of the TalenTec Shares;

(5) the
 certified true copies of the certificate of incorporation and the latest constitution, Return for Allotment of Shares, Notification
 for Change in the Registered Address, Notification of Change in the Register of Directors, Managers and Secretaries of TalenTec;
 and

(6) where
 relevant and applicable, the certified true copy of all the relevant approvals, consents, permits and/or waivers obtained, as the
 case may be, in respect of the transactions contemplated by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) BSKE
 shall deliver to Shareholders the following documents:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) certified
 true copies of the resolutions of board meeting of BSKE approving the issuance of the BSKE Shares to the Shareholders in accordance
 with the terms of the Merger Agreement;

(2) a
 certified true copy of the resolutions being passed at a board meeting of BSKE approving the allotment of the BSKE Shares to the
 Shareholders in accordance with the terms of the Merger Agreement, as the legal and beneficial holders of BSKE Shares;

(3) such
 waivers, consents and/or documents, if any, as BSKE may require to enable the Shareholders to be registered as the holders of the
 BSKE Shares in the register of members of BSKE; and

(4) where
 relevant and applicable, the certified true copy of all the relevant approvals, consents, permits and/or waivers obtained, as the
 case may be, in respect of the transactions contemplated by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;**4.** **Survival of Representations and Warranties.** 

None of the representations, warranties and covenants of Shareholders TalenTec, or BSKE hereto contained in this Agreement shall survive the Closing, except that the representations and warranties contained in Section 2(a), Section 2(b)(i), Section 2(b)(ii), Section 2(c)(i), Section 2(c)(ii) and Section 2(c)(iii) shall survive until the latest date permitted by applicable law. Except as specifically set forth in the preceding sentence, no other representation, warranty or covenant of any Party set forth in this Agreement will survive the Closing, and no Party will have any rights or remedies after the Closing with respect to any misrepresentation of or inaccuracy in any such representation, warranty or covenant.

&nbsp;&nbsp;&nbsp;&nbsp;**5.** **Shareholders Representative/Power of Attorney.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Each
 of Eddie Tan Chee Wei, Koay Chee Leong, Goh Chee Siong, Danny Vincent Dass ()"**Other Shareholders** "), on behalf of
 himself and his successors and assigns, hereby irrevocably constitutes and appoints Leow Kian Yong, as his true and lawful agent
 and attorney-in-fact with full powers of substitution to act in the name, place and stead of thereof (the "Company Shareholder
 Representative") with respect to the performance on behalf of each of the Other Shareholders under the terms and provisions
 of this Agreement and the Merger Agreement and any other documents to be executed by any of the Other Shareholders pursuant to or
 in connection with this Agreement or the Merger Agreement (together with this Agreement and the Merger Agreement, the "**Shareholders Representative Documents** "), as the same may be from time to time amended, and to do or refrain from doing all such further
 acts and things, and to execute all such documents on behalf of any of the Other Shareholders, if any, as the Company Shareholder
 Representative will deem necessary or appropriate in connection with any of the transactions contemplated under the Shareholders
 Representative Documents, including (i) terminating, amending or waiving on behalf of any of the Other Shareholders any provision
 of any Shareholders Representative Document (provided, that any such action, if material to the rights and obligations of the Other
 Shareholders in the reasonable judgment of the Company Shareholder Representative, will be taken in the same manner with respect
 to all Shareholders and unless otherwise agreed by each of the Other Shareholders who is subject to any disparate treatment of a
 potentially material and adverse nature); (ii) signing on behalf of any of the Other Shareholders any releases or other documents
 with respect to any dispute or remedy arising under any Shareholders Representative Document; (iii) employing and obtaining the advice
 of legal counsel, accountants and other professional advisors as the Company Shareholder Representative, in his reasonable discretion,
 deems necessary or advisable in the performance of his duties as the Company Shareholder Representative and to rely on their advice
 and counsel; (iv) incurring and paying reasonable costs and expenses, including fees of brokers, attorneys and accountants incurred
 pursuant to the transactions contemplated hereby, and any other reasonable fees and expenses allocable or in any way relating to
 such transaction or any indemnification claim, whether incurred prior or subsequent to the Closing and the closing of the Merger
 Agreement; (v) receiving all or any portion of the consideration provided to the Other Shareholders under this Agreement and the
 Merger Agreement and to distribute the same to the Other Shareholders in accordance with their pro rata shares; and (vi) otherwise
 enforcing the rights and obligations of any of the Other Shareholders under any Shareholders Representative Document, including giving
 and receiving all notices and communications hereunder or thereunder on behalf of the Other Shareholders. All decisions and actions
 by the Company Shareholder Representative shall be binding upon each of the Other Shareholders and their respective successors and
 assigns, and neither they nor any other parties shall have the right to object, dissent, protest or otherwise contest the same. The
 provisions of this Section 5 are irrevocable and coupled with an interest. Leow Kian Yong hereby accepts his appointment and authorization
 as the Company Shareholders Representative under this Agreement and the Merger Agreement.

(b) Any
 other person, including BSKE and TalenTec, may conclusively and absolutely rely, without inquiry, upon any actions of the Company
 Shareholder Representative as the acts of the Other Shareholders under any Shareholders Representative Documents. BSKE and TalenTec
 shall be entitled to rely conclusively on the instructions and decisions of the Company Shareholder Representative as to (i) any
 payment instructions provided by the Company Shareholder Representative or (ii) any other actions required or permitted to be taken
 by the Company Shareholder Representative under this Agreement or the Merger Agreement, and the Other Shareholders shall not have
 any cause of action against BSKE, TalenTec or any other indemnified party for any action taken by any of them in reliance upon the
 instructions or decisions of the Company Shareholder Representative. BSKE and TalenTec shall not have any liability to any of the
 Other Shareholders for any allocation or distribution among the Other Shareholders by the Company Shareholder Representative of payments
 made to or at the direction of the Company Shareholder Representative. All notices or other communications required to be made or
 delivered to any of the Other Shareholders under any Shareholders Representative Document shall be made to the Company Shareholder
 Representative for the benefit of such Other Shareholder, and any notices so made shall discharge in full all notice requirements
 of the other parties hereto or thereto to such Other Shareholder with respect thereto. All notices or other communications required
 to be made or delivered by any of the Other Shareholders shall be made by the Company Shareholder Representative (except for a notice
 under Section 5(d) of the replacement of the Company Shareholder Representative).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The
 Company Shareholder Representative will act for the Other Shareholders on all of the matters set forth in this Agreement and the
 Merger Agreement in the manner the Company Shareholder Representative believes to be in the best interests of the Other Shareholders,
 but the Company Shareholder Representative will not be responsible to the Other Shareholders for any losses that any of the Other
 Shareholders may suffer by reason of the performance by the Company Shareholder Representative of his duties under this Agreement
 or the Merger Agreement or any Shareholders Representative Document, other than losses arising from the bad faith, gross negligence
 or wilful misconduct by the Company Shareholder Representative in the performance of his duties under this Agreement or the Merger
 Agreement or any Shareholders Representative Document. From and after the Closing and the closing of the Merger Agreement, the Other
 Shareholders shall jointly and severally indemnify, defend and hold the Company Shareholder Representative harmless from and against
 any and all losses reasonably incurred without gross negligence, bad faith or willful misconduct on the part of the Company Shareholder
 Representative (in his capacity as such) and arising out of or in connection with the acceptance or administration of the Company
 Shareholder Representative's duties under any Shareholders Representative Document, including the reasonable fees and expenses
 of any legal counsel retained by the Company Shareholder Representative. In no event shall the Company Shareholder Representative
 in such capacity be liable hereunder or in connection herewith for any indirect, punitive, special or consequential damages. The
 Company Shareholder Representative shall not be liable for any act done or omitted under any Shareholders Representative Document
 as the Company Shareholder Representative while acting in good faith and without willful misconduct or gross negligence, and any
 act done or omitted pursuant to the advice of counsel shall be conclusive evidence of such good faith. The Company Shareholder Representative
 shall be fully protected in relying upon any written notice, demand, certificate or document that it in good faith believes to be
 genuine, including facsimiles or copies thereof, and no person shall have any liability for relying on the Company Shareholder Representative
 in the foregoing manner. In connection with the performance of his rights and obligations hereunder, the Company Shareholder Representative
 shall have the right at any time and from time to time to select and engage, at the reasonable cost and expense of the Other Shareholders,
 solicitors and advocate, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional
 and expert assistance, maintain such records and incur other reasonable out-of-pocket expenses, as the Company Shareholder Representative
 may reasonably deem necessary or appropriate from time to time. All of the indemnities, immunities, releases and powers granted to
 the Company Shareholder Representative under this Section 5 shall survive the Closing and the closing of the Merger Agreement and
 continue indefinitely.

(d) If
 the Company Shareholder Representative shall die, become disabled, dissolve, resign or otherwise be unable or unwilling to fulfill
 his responsibilities as representative and agent of the Other Shareholders, then the Other Shareholders shall, within ten (10) days
 after such death, disability, dissolution, resignation or other event, appoint a successor Company Shareholder Representative (by
 vote or written consent of the Other Shareholders holding in the aggregate majority equity interests of TalenTec), and promptly thereafter
 (but in any event within two (2) Business Days after such appointment) notify BSKE and TalenTec in writing of the identity of such
 successor. Any such successor so appointed shall become the "**Company Shareholder Representative**" for purposes
 of this Agreement and the Merger Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;**6.** **General Provisions.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **Releases and Waivers of Shareholders**. Each of the Shareholders on its own behalf hereby acknowledges and agrees that the number of TalenTec
 Shares set forth on <u>Schedule A</u> represents the total number of ordinary shares of TalenTec held by such Shareholder as of the
 date of this Agreement and as of the Closing. Each of the Shareholders hereby releases TalenTec and BSKE from all obligations, liabilities
 and causes of action arising before, on or after the date of this Agreement, out of or in relation to any entitlement which such
 Shareholder may have with respect to any TalenTec Shares in excess of the number of TalenTec Shares set forth on <u>Schedule A</u>.
 Each of the Shareholders hereby generally, irrevocably, unconditionally and completely waives any and all rights to receive any anti-dilution
 protection to which such Shareholder may be entitled under the constitution or charter or memorandum and articles of association
 or incorporation documents, as applicable, of TalenTec or under any other agreement or instrument in connection with the Exchange.
 Except for the BSKE Shares to be issued in connection with the Exchange, each of the Shareholders hereby generally, irrevocably,
 unconditionally and completely waives any and all rights existing as of the date hereof to receive options, depository receipts,
 warrants, stock appreciation or similar rights to acquire or receive ordinary shares or other securities in TalenTec or BSKE.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **Governing Law**. This Agreement is to be construed in accordance with and governed by the laws of Malaysia.

(c) **Arbitration**.
 Any claim, dispute or controversy among the Parties arising out of or relating to this Agreement, including the breach thereof, which
 cannot be satisfactorily settled by the Parties, will be finally and exclusively settled by confidential and binding arbitration
 ()"**Arbitration**") upon the written request of any party. The Arbitration shall be administered by Asian International
 Arbitration Centre ()"**AIAC**") in accordance with the AIAC Arbitration Rules for the time being in force and which
 rules are deemed to be incorporated by reference in this section, to which each Party agrees to submit for these purposes. The result
 of the arbitration shall be final and binding on the Parties and will be the sole and exclusive remedy between the Parties regarding
 any claims, counterclaims, issues or accountings presented or pleaded to the arbitrator. Judgment on any arbitration award may be
 entered in any court having jurisdiction. The seat of the arbitration shall be Malaysia. The language to be used in the arbitration
 proceedings shall be English and there shall be 3 arbitrators. Such arbitrators shall be selected pursuant to the following procedure:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Within
 fifteen (15) Business Days of notice by a Party seeking arbitration, TalenTec and Shareholders shall collectively appoint one (1)
 person as an arbitrator and BSKE shall appoint one (1) person as an arbitrator.

(ii) Within
 fifteen (15) Business Days after the appointment of the two (2) arbitrators, the two chosen arbitrators shall mutually agree upon
 the selection of the third impartial and neutral arbitrator.

(iii) In
 the event the two chosen arbitrators cannot agree upon the selection of the third arbitrator, the director of AIAC shall make the
 selection in his discretion, except that such third arbitrator shall be appointed from an independent accounting firm or investment
 bank.

(iv) If
 the other Party shall fail to designate the second arbitrator, the sole arbitrator appointed shall have the power to appoint, in
 his sole discretion, both the second and third arbitrators.

(v) If
 a Party fails to appoint a successor to his appointed arbitrator within fifteen (15) Business Days of the death, resignation or other
 incapacity of such arbitrator, the remaining two arbitrators shall appoint such successor.

(vi) The
 majority decision of the arbitrators will be final and conclusive upon the Parties and for the avoidance of doubt, the arbitrators
 shall have full power to address all discovery and evidential issues, and to make finding of fact and of law in accordance with the
 AIAC Arbitration Rules for the time being in force and each arbitrator will be compensated at rates generally commensurate with his
 normal billing rates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) **Severability**.
 If any provision of this Agreement is held by a court or other tribunal of competent jurisdiction to be invalid or unenforceable
 for any reason, the remaining provisions shall continue in full force and effect without being impaired or invalidated in any way,
 and the Parties agree to replace any invalid provision with a valid provision which most closely approximates the intent and economic
 effect of the invalid provision.

(e) **Waiver**.
 The waiver by any Party of a breach of or default under any provision of this Agreement shall not be effective unless in writing
 and signed by the Party granting the waiver and shall not be construed as a waiver of any subsequent breach of or default under the
 same or any other provision of this Agreement. Further, any failure or delay on the part of any Party to exercise or avail itself
 of any right or remedy that it has or may have hereunder shall not operate as a waiver of any such right or remedy or preclude other
 or further exercise thereof or of any other right or remedy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) **Notices**.
 Any notices required or permitted hereunder shall be given to the appropriate Party at the address specified below or at such other
 address as the Party may specify in writing. Such notice shall be deemed given: (i) if delivered personally, upon delivery as evidenced
 by delivery records; (ii) if sent by telephone facsimile, upon confirmation of receipt; (iii) if sent by pre-paid first class post
 or recorded delivery or by commercial courier, five (5) days after the date of mailing; of (iv) if sent by nationally recognized
 express courier, two (2) Business Days after date of placement with such courier.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) In
 case of TalenTec

TalenTec Sdn. Bhd.

Address: Room 202, 2nd Floor, 368, Jalan Pudu, 55100 Kuala Lumpur

Fax: 03-21433109

Email: msasb81@gmail.com

Attention: Ms Vinnie Yap

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) In
 case of any Shareholder, to that Shareholder, in care of the Company Shareholder Representative,
 at his address set forth on Schedule A, who will promptly transmit the notice to the Shareholder
 receiving the notice at his address set forth on Schedule A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) In
 case of BSKE

BLACK TITAN CORPORATION (F/K/A BSKE LIMITED)

Address: 4th Floor, Harbour Place, 103 South Church Street, PO Box 10240, Grand Cayman, KY1-1002 Cayman Islands.

Email: brynner.chiam@blackchambermgmt.com

Attention: Mr. Brynner Chiam

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) **No Third Party Beneficiaries**. Nothing in this Agreement shall be construed to confer any rights or benefits upon any person other
 than the Parties hereto, and no other person shall have any rights or remedies hereunder.

(h) **Public Announcements**. Each of the Shareholders shall not issue any press release or make any other public statements with respect to
 this Agreement and the transaction contemplated hereby without the written consent of TalenTec and BSKE, except as may be required
 by applicable law, court process or by obligations pursuant to any listing agreement with any national securities exchange.

(i) **Termination**.
 This Agreement may be terminated upon written notice at any time prior to Closing by mutual written consent of the Parties. This
 Agreement shall terminate automatically upon termination of the Merger Agreement pursuant to its terms. Termination of this Agreement
 will terminate all rights and obligations of the Parties under this Agreement, and this Agreement will become void and have no force
 or effect.

(j) **Entire Agreement**. This Agreement and the Merger Agreement constitute the entire agreement among the Parties and supersedes all prior
 oral and written agreements among the Parties hereto with respect to the subject matter hereof.

(k) **Counterparts**.
 This Agreement may be executed in one or more counterparts (including electronic counterparts) each of which shall be deemed an original
 and all of which shall be taken together and deemed to be one instrument.

(l) **Business Day**. For the purposes of this Agreement, "**Business Day**" means a day (other than a Saturday, Sunday or a gazetted
 public holiday in Malaysia) when banks are open for banking business in Malaysia.

[*Remainder of Page Intentionally Left Blank.*]

**Execution Page**

---

| | |
|:---|:---|
| **<u>BSKE</u>** | **<u>BSKE</u>** |
| SIGNED FOR AND ON BEHALF OF | SIGNED FOR AND ON BEHALF OF |
| **BLACK TITAN CORPORATION (F/K/A BSKE LIMITED)** | **BLACK TITAN CORPORATION (F/K/A BSKE LIMITED)** |
| By: | */s/ Brynner Chiam* |
| Name: | Brynner Chiam |
| Title: | Director |

---

---

| | |
|:---|:---|
| **<u>TalenTec</u>** | **<u>TalenTec</u>** |
| SIGNED FOR AND ON BEHALF OF | SIGNED FOR AND ON BEHALF OF |
| **TALENTEC SDN BHD** (Company No. 199001001889 (193451-W)) | **TALENTEC SDN BHD** (Company No. 199001001889 (193451-W)) |
| By: | */s/ Ho Say San* |
| Name: | Ho Say San |
| Title: | Director |

---

---

| |
|:---|
| **<u>Shareholders</u>** |
| SIGNED BY |
| **DANNY VINCENT DASS** (Malaysian National Registration Identity Card No.:) |
| */s/ Danny Vincent Dass* |

---

**CERTIFICATE OF AUTHENTICATION**

I, Vincent Chan Siew Onn, \*(Magistrate, Justice of the Peace, Land Administrator, Notary Public, Commissioner for Oaths, Bank Official or Advocate and Solicitor of the High Court in Malaya practising at Kuala Lumpur), hereby certify that the signature written of the donor above, was in my presence on this 25 Jul 2025 day of _______________________ 2025, and is, to my own personal knowledge, the true signature of Danny Vincent Dass (NRIC No. _________), who has acknowledged to me that he is of full age and that he has voluntarily executed this instrument.

Witness my hand

---

| |
|:---|
| */s/ Vincent Chan Siew Onn* |
| Vincent Chan Siew Onn (BC/C/645) |
| Advocate & Solicitor |
| Kuala Lumpur |

---

---

| |
|:---|
| SIGNED BY |
| **EDDIE TAN CHEE WEI** (Malaysian National Registration Identity Card No.:) |
| */s/ Eddie Tan Chee Wei* |

---

**CERTIFICATE OF AUTHENTICATION**

I, Vincent Chan Siew Onn, \*(Magistrate, Justice of the Peace, Land Administrator, Notary Public, Commissioner for Oaths, Bank Official or Advocate and Solicitor of the High Court in Malaya practising at Kuala Lumpur), hereby certify that the signature written of the donor above, was in my presence on this 25 Jul 2025 day of _______________________ 2025, and is, to my own personal knowledge, the true signature of Eddie Tan Chee Wei (NRIC No. _________), who has acknowledged to me that he is of full age and that he has voluntarily executed this instrument.

Witness my hand

---

| |
|:---|
| */s/ Vincent Chan Siew Onn* |
| Vincent Chan Siew Onn (BC/C/645) |
| Advocate & Solicitor |
| Kuala Lumpur |

---

---

| |
|:---|
| SIGNED BY |
| **KOAY CHEE LEONG** (Malaysian National Registration Identity Card No.:) |
| */s/ Koay Chee Leong* |

---

**CERTIFICATE OF AUTHENTICATION**

I, Vincent Chan Siew Onn, \*(Magistrate, Justice of the Peace, Land Administrator, Notary Public, Commissioner for Oaths, Bank Official or Advocate and Solicitor of the High Court in Malaya practising at Kuala Lumpur), hereby certify that the signature written of the donor above, was in my presence on this 25 Jul 2025 day of _______________________ 2025, and is, to my own personal knowledge, the true signature of Koay Chee Leong ((NRIC No. _________) who has acknowledged to me that he is of full age and that he has voluntarily executed this instrument.

Witness my hand

---

| |
|:---|
| */s/ Vincent Chan Siew Onn* |
| Vincent Chan Siew Onn (BC/C/645) |
| Advocate & Solicitor |
| Kuala Lumpur |

---

---

| |
|:---|
| SIGNED BY |
| **LEOW KIAN YONG** (Malaysian National Registration Identity Card No.:) |
| ***/s****/ Leow Kian Yong* |

---

**CERTIFICATE OF AUTHENTICATION**

I, Vincent Chan Siew Onn, \*(Magistrate, Justice of the Peace, Land Administrator, Notary Public, Commissioner for Oaths, Bank Official or Advocate and Solicitor of the High Court in Malaya practising at Kuala Lumpur), hereby certify that the signature written of the donor above, was in my presence on this 25 Jul 2025 day of _______________________ 2025, and is, to my own personal knowledge, the true signature of Leow Kian Yong (NRIC No. _________), who has acknowledged to me that he is of full age and that he has voluntarily executed this instrument.

Witness my hand

---

| |
|:---|
| */s/ Vincent Chan Siew Onn* |
| Vincent Chan Siew Onn (BC/C/645) |
| Advocate & Solicitor |
| Kuala Lumpur |

---

---

| |
|:---|
| SIGNED BY |
| **GOH CHEE SIONG** ((Malaysian National Registration Identity Card No.:) |
| */s/ Goh Chee Siong* |

---

**CERTIFICATE OF AUTHENTICATION**

I, Vincent Chan Siew Onn, \*(Magistrate, Justice of the Peace, Land Administrator, Notary Public, Commissioner for Oaths, Bank Official or Advocate and Solicitor of the High Court in Malaya practising at Kuala Lumpur), hereby certify that the signature written of the donor above, was in my presence on this 25 Jul 2025 day of _______________________ 2025, and is, to my own personal knowledge, the true signature of Goh Chee Siong (NRIC No. _________), who has acknowledged to me that he is of full age and that he has voluntarily executed this instrument.

Witness my hand

---

| |
|:---|
| */s/ Vincent Chan Siew Onn* |
| Vincent Chan Siew Onn (BC/C/645) |
| Advocate & Solicitor |
| Kuala Lumpur |

---

**Schedule A**

---

| | | | |
|:---|:---|:---|:---|
| **No.** | **Name of Shareholder** | **Shares in TalenTec** | **Shares in TalenTec** |
| 1 | Danny Vincent Dass <br>Address: <br>Email: |  | 275000 |
| 2 | Eddie Tan Chee Wei <br>Address: <br>Email: |  | 75000 |
| 3 | Koay Chee Leong <br>Email: |  | 75000 |
| 4 | Leow Kian Yong <br>Address: <br>Email: |  | 75000 |
| 5 | Goh Chee Siong <br>Address:. <br>Email: |  | 80000 |

---